{"gene":"NFAT5","run_date":"2026-06-10T05:19:52","timeline":{"discoveries":[{"year":1999,"finding":"NFAT5 contains an NFAT-like Rel homology domain, binds DNA sequences similar to NFAT1-4 target sites, but lacks the majority of Fos/Jun contact residues and does not bind cooperatively with Fos and Jun to DNA. Unlike NFAT1-4, NFAT5 is constitutively nuclear and its nuclear localization is not regulated by calcineurin-mediated dephosphorylation.","method":"DNA binding assays, co-transfection/reporter assays, immunofluorescence localization, sequence analysis of contact residues","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — multiple orthogonal biochemical methods (DNA binding, reporter assay, localization) in a foundational study; widely replicated across subsequent literature","pmids":["10377394"],"is_preprint":false},{"year":2002,"finding":"Crystal structure of TonEBP/NFAT5 Rel homology domain bound to DNA reveals that TonEBP adopts an NF-κB-like homodimeric structure and completely encircles its TonE DNA target, providing increased kinetic stability of the DNA complex.","method":"X-ray crystallography, electrophoretic mobility shift assay (EMSA), biochemical DNA-binding kinetics","journal":"Nature structural biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure with biochemical validation of DNA encirclement mechanism","pmids":["11780147"],"is_preprint":false},{"year":2002,"finding":"Dimerization of TonEBP via the C-terminus of the Rel homology domain (CRHD) is required for DNA binding and proper phosphorylation (especially under hypertonic conditions); deletion of the CRHD abolishes DNA binding and eliminates dominant-negative activity.","method":"Biochemical dimerization assays, deletion mutagenesis, DNA binding assays, phosphorylation analysis","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct mutagenesis and functional readouts in a single focused study","pmids":["12074571"],"is_preprint":false},{"year":2002,"finding":"The C-terminal transactivation domain (TAD; 983 C-terminal amino acids) of TonEBP/OREBP is osmotically regulated at the post-translational level, with activity decreasing >80% at low osmolality and increasing 8-fold at high NaCl, dependent on tonicity-driven phosphorylation. Tyrosine kinase inhibitor herbimycin and CK2 inhibitor DRB reduce TAD activity, implicating these kinases.","method":"GAL4-TAD fusion reporter assay in HepG2 cells, pharmacological kinase inhibition","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean reporter assay with multiple inhibitors in one study, single lab","pmids":["11792870"],"is_preprint":false},{"year":2002,"finding":"p38 MAPK and Fyn tyrosine kinase are both required for maximal hypertonic activation of OREBP/TonEBP; the transactivation domain is the target of p38- and Fyn-mediated activation. Combined inhibition of p38 in Fyn-deficient cells almost completely abolishes hypertonic ORE reporter induction.","method":"Dominant-negative mutants, pharmacological inhibition (SB203580), Fyn-deficient cells, ORE reporter assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic (DN mutants, KO cells) and pharmacological approaches with epistasis analysis, replicated across multiple conditions","pmids":["12359721"],"is_preprint":false},{"year":2004,"finding":"ATM kinase, activated by high NaCl-induced DNA damage via autophosphorylation at Ser-1981, contributes to TonEBP/OREBP activation. TonEBP/OREBP physically associates with ATM (reciprocal co-IP), ATM phosphorylates TonEBP at consensus sites (Ser-1197, Ser-1247, Ser-1367), and mutation of these sites reduces TonEBP transcriptional activity.","method":"Co-immunoprecipitation, site-directed mutagenesis (S1197A, S1247A, S1367A), ATM-deficient (AT) cells, wortmannin inhibition, EMSA supershift","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — reciprocal Co-IP, mutagenesis of phosphorylation sites, genetic reconstitution in AT cells, multiple orthogonal methods","pmids":["15173573"],"is_preprint":false},{"year":2005,"finding":"High NaCl stabilizes TonEBP/OREBP mRNA (via its 5'-UTR, not the 3'-UTR), which accounts for the increase in mRNA abundance without requiring increased transcription.","method":"Actinomycin D chase assay, luciferase reporters containing 5'- and 3'-UTR fragments","journal":"American journal of physiology. Renal physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct mRNA stability measurement plus UTR reporter assays, single lab","pmids":["15900024"],"is_preprint":false},{"year":2005,"finding":"ATM kinase also contributes to high NaCl-induced nuclear translocation of TonEBP/OREBP; nuclear localization of TonEBP and its N-terminal Rel homology domain is reduced in ATM-deficient (AT) cells and restored by reconstitution with functional ATM.","method":"Western blot of nuclear/cytoplasmic fractions, ATM-deficient cells, wortmannin inhibition, genetic reconstitution","journal":"American journal of physiology. Renal physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic complementation in AT cells, fractionation assay, single lab","pmids":["15840767"],"is_preprint":false},{"year":2005,"finding":"High NaCl increases reactive oxygen species (specifically superoxide from mitochondrial complexes I and III), which contribute to TonEBP/OREBP activation by increasing its transactivating activity but not nuclear translocation.","method":"Pharmacological inhibitors (rotenone, myxothiazol, NAC, MnTBAP), ORE/TonE reporter assay, BGT1 mRNA measurement","journal":"American journal of physiology. Renal physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple inhibitors targeting specific ROS sources, functional reporter and mRNA readouts, single lab","pmids":["15769933","16303854"],"is_preprint":false},{"year":2006,"finding":"TonEBP is physically associated in vivo with RNA helicase A (RHA), which binds the E'F loop of the DNA-binding domain. Overexpression of RHA inhibits TonEBP activity; elevated tonicity decreases the TonEBP-RHA interaction, suggesting RHA dissociation is a mechanism for TonEBP activation.","method":"Co-immunoprecipitation, domain mapping, overexpression, reporter assays","journal":"The Biochemical journal","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — Co-IP with domain mapping and functional assay, single lab","pmids":["16173919"],"is_preprint":false},{"year":2006,"finding":"TonEBP/OREBP nuclear export under isotonic conditions is mediated by a CRM1-dependent leucine-rich nuclear export sequence (NES) in the N-terminus; hypotonicity-induced nuclear export additionally requires a distinct auxiliary export domain. CRM1 physically interacts with TonEBP, demonstrated by bimolecular fluorescence complementation.","method":"Immunocytochemistry, GFP fusions, site-directed mutagenesis of NES, bimolecular fluorescence complementation assay, leptomycin B treatment","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — mutagenesis, protein-protein interaction assay, multiple constructs, clear functional domain mapping","pmids":["16782704"],"is_preprint":false},{"year":2006,"finding":"Proteomic analysis identified 14 proteins physically associated with TonEBP/OREBP in nuclei under high NaCl conditions, including DNA-PK (catalytic subunit and Ku86), RNA helicases (RHA, nucleolar RNA helicase II/Gu, DEAD-box p72), several hnRNPs and snRNPs, Hsp90β, Hsc70, and PARP-1. PARP-1 reduces TonEBP transcriptional and transactivating activities, while Hsp90 enhances them and sustains TonEBP protein abundance.","method":"Stable expression of N-terminal TonEBP fragment, immunoprecipitation, mass spectrometry, Western blot confirmation, EMSA, reporter assays","journal":"American journal of physiology. Renal physiology","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — MS-based proteomics confirmed by Western, EMSA, and functional reporter assays with multiple interactors validated","pmids":["17148781"],"is_preprint":false},{"year":2008,"finding":"p38α and p38δ isoforms have opposing effects on TonEBP/OREBP activity: p38α increases TonEBP activity while p38δ decreases it. Overexpression of MKP-1 inhibits both p38 isoforms but has no net effect on TonEBP/OREBP activity due to these opposing actions.","method":"siRNA knockdown of p38 isoforms, overexpression of dominant-negative MKP-1, TonEBP reporter assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — isoform-specific siRNA knockdown and overexpression with reporter assay, single lab","pmids":["18367666"],"is_preprint":false},{"year":2009,"finding":"Phospholipase C-γ1 (PLC-γ1) contributes to TonEBP/OREBP activation by high NaCl. High NaCl induces phosphorylation of TonEBP at Y143; phospho-Y143 creates a binding site for PLC-γ1 (reciprocal co-IP, abolished by Y143A mutation); PLC-γ1 promotes TonEBP transactivating activity and nuclear localization, and is present in the TonEBP-DNA complex.","method":"PLC-γ1 null cells, siRNA knockdown, co-immunoprecipitation, Y143A mutagenesis, nuclear localization assay, reporter assay, EMSA","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — null cells, mutagenesis, reciprocal Co-IP, multiple orthogonal functional readouts in one study","pmids":["20080774"],"is_preprint":false},{"year":2009,"finding":"Inducible nucleosome depletion occurs at OREBP/TonEBP binding sites (OREs) in response to hypertonic stress. Initial nucleosome loss is OREBP-independent but is potentiated by OREBP; OREBP-dependent histone hyperacetylation spans the 5' upstream sequences and exons of the aldose reductase gene, but nucleosome loss is not regulated by acetylation status.","method":"Chromatin immunoprecipitation (ChIP), nucleosome occupancy assays, aldose reductase promoter analysis","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP-based chromatin analysis with OREBP-dependent and -independent conditions, single lab","pmids":["20041176"],"is_preprint":false},{"year":2010,"finding":"SHP-1 protein tyrosine phosphatase dephosphorylates TonEBP/OREBP at Y143 both in vivo and in vitro, reducing TonEBP nuclear localization and transactivating activity. SHP-1 co-immunoprecipitates with TonEBP. High NaCl inhibits SHP-1 by increasing its phosphorylation at Ser591, which reduces SHP-1 phosphatase activity and nuclear localization, thereby enabling TonEBP activation.","method":"Genome-wide phosphatase siRNA screen, siRNA knockdown, overexpression, in vitro phosphatase assay, co-immunoprecipitation, nuclear fractionation","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — genome-wide screen followed by in vitro phosphatase assay, Co-IP, and multiple functional assays; single lab but rigorous multi-method validation","pmids":["20351292"],"is_preprint":false},{"year":2010,"finding":"c-Abl kinase is responsible for high NaCl-induced phosphorylation of TonEBP/OREBP at Y143 in cell culture and in rat renal inner medulla in vivo. c-Abl associates with TonEBP (co-immunoprecipitation), phosphorylates TonEBP-Y143 in vitro, and its inhibition (imatinib, siRNA, kinase-dead mutant) drastically reduces TonEBP nuclear localization and transactivating activity. High NaCl-induced ATM activation depends on c-Abl activity.","method":"Co-immunoprecipitation, in vitro kinase assay, imatinib treatment, siRNA, kinase-dead construct, nuclear fractionation, in vivo renal inner medulla analysis","journal":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — in vitro kinase assay plus Co-IP plus multiple genetic and pharmacological approaches plus in vivo validation","pmids":["20585028"],"is_preprint":false},{"year":2010,"finding":"TonEBP interacts with NF-κB p65 in a tonicity-dependent manner and enhances NF-κB activity at κB elements of NF-κB-responsive genes. This interaction is dependent on Akt signaling. TonEBP affects neither IκBα degradation nor p65 nuclear translocation but acts as a cofactor enhancing NF-κB transcriptional output.","method":"Co-immunoprecipitation, reporter assays, kinase inhibition, knockdown in renal epithelial cells and macrophages","journal":"Molecular biology of the cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP with functional reporter assays in two cell types, single lab","pmids":["20685965"],"is_preprint":false},{"year":2011,"finding":"CDK5, activated by high NaCl, directly phosphorylates TonEBP/OREBP at Thr135 (identified by mass spectrometry), contributing to its rapid nuclear localization. Inhibition of CDK5 reduces early (≤4 h) but not late nuclear TonEBP accumulation and transcriptional activity. S155A mutation increases nuclear localization while S134A/T135A mutations decrease it.","method":"Mass spectrometry phospho-site mapping, site-directed mutagenesis, CDK5 inhibition, nuclear fractionation, reporter assay, in vivo rat renal medulla phosphorylation analysis","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — mass spectrometry-defined site, mutagenesis, in vitro kinase activity, genetic inhibition, and in vivo verification","pmids":["21209322"],"is_preprint":false},{"year":2011,"finding":"Rac1 and its scaffold OSM (osmosensing scaffold for MEKK3) support TonEBP/OREBP transcriptional/transactivating activity via PLC-γ1, not via p38 MAPK. siRNA knockdown of Rac1 or OSM reduces TonEBP activity; this effect is abolished in PLC-γ1-null cells and restored by PLC-γ1 reconstitution.","method":"siRNA knockdown, PLC-γ1 null cells, reconstitution, reporter assay, phosphorylation analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic null cells with reconstitution and epistasis analysis, single lab","pmids":["21712438"],"is_preprint":false},{"year":2013,"finding":"GSK-3β inhibits TonEBP/NFAT5 by suppressing its transactivating activity (not nuclear localization or protein abundance). High NaCl activates PKA, PI3K, and AKT1 which phosphorylate GSK-3β at Ser9, inhibiting GSK-3β and thereby relieving its suppression of TonEBP.","method":"siRNA knockdown, GSK-3β null MEFs, S9A GSK-3β mutant transfection, overexpression of PKA/AKT/p38, reporter assay","journal":"American journal of physiology. Renal physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — null MEFs with reconstitution, phosphorylation site mutagenesis, multiple kinase manipulations, single lab","pmids":["23324178"],"is_preprint":false},{"year":2013,"finding":"IKKβ regulates NFAT5 expression in thymocytes; NFAT5 in turn promotes survival of TCRαβ thymocytes and the β-selection checkpoint transition in an osmostress-independent manner by regulating pro-survival factors A1 and Bcl2 and attenuating the p53/Noxa axis.","method":"NFAT5-deficient mice, T cell-specific NFAT5 knockout, IKKβ manipulation, apoptosis assays, gene expression analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO mouse models with defined cellular and molecular phenotypes, single lab","pmids":["24043824"],"is_preprint":false},{"year":2014,"finding":"PKC-α contributes to high NaCl-dependent NFAT5 activation through ERK1/2 (not through SHP-1-S591). PKC-α knockout reduces NFAT5 protein and target gene expression in the inner medulla, and PKC-α knockdown attenuates NFAT5 transcriptional and transactivating activity; combined knockdown of PKC-α and ERK2 is not additive, indicating a common pathway.","method":"PKC-α knockout mice, siRNA knockdown, ERK1/2 phosphorylation analysis, reporter assay, in vivo renal medulla analysis","journal":"American journal of physiology. Renal physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo KO plus cell-based siRNA epistasis, single lab","pmids":["25391900"],"is_preprint":false},{"year":2016,"finding":"TonEBP is required for LPS-induced NF-κB enhanceosome activity in macrophages by recruiting the co-activator p300 to NF-κB; TonEBP molecules incapable of recruiting p300 do not stimulate NF-κB. Myeloid-specific TonEBP deletion reduces inflammation and sepsis severity. The natural compound cerulenin disrupts this TonEBP/NF-κB/p300 enhanceosome without affecting NF-κB activation itself.","method":"Myeloid-specific conditional KO mice, p300-recruitment-deficient TonEBP mutants, reporter assays, co-immunoprecipitation, cerulenin treatment, sepsis model","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO in vivo, structure-function mutants for p300 recruitment, mechanistic inhibitor studies; multiple orthogonal methods","pmids":["27118681"],"is_preprint":false},{"year":2019,"finding":"TonEBP acts as an epigenetic suppressor of white adipose tissue beiging by recruiting DNMT1 DNA methylase to the β3-adrenoreceptor gene promoter, causing promoter methylation and transcriptional silencing. Adipocyte-specific TonEBP deletion or haploinsufficiency prevents high-fat diet-induced obesity and metabolic defects.","method":"Adipocyte-specific and haploinsufficient mouse models, ChIP, DNMT1 recruitment assay, promoter methylation analysis, ex vivo and cultured adipocyte reporter assays","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — conditional KO mouse, ChIP showing DNMT1 recruitment, promoter methylation, in vivo metabolic phenotype with multiple orthogonal methods","pmids":["31387996"],"is_preprint":false},{"year":2019,"finding":"NFAT5 is selectively required for CD8+ T cell exhaustion in the tumor microenvironment but not during chronic viral infection. NFAT5 transcriptional activity in the tumor context requires hyperosmolarity. NFAT5 overexpression reduces tumor control; deletion reduces TOX and PD-1 expression and increases cytokine production in precursor exhausted PD-1+TCF1+TIM-3- CD8+ T cells.","method":"NFAT5 conditional KO mice, NFAT5 overexpression in CD8+ T cells, tumor implantation and LCMV clone 13 infection models, flow cytometry, cytokine assays","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — gain- and loss-of-function in vivo genetic models with defined molecular and cellular phenotypes, comparison of two distinct in vivo contexts","pmids":["37709986"],"is_preprint":false},{"year":2021,"finding":"TonEBP recognizes R-loops (RNA-DNA hybrids) generated by DNA damaging agents (UV, CPT), binds R-loops via both 3D collision and 1D diffusion along DNA in vitro, and recruits METTL3 to R-loops through its Rel homology domain to promote m6A RNA methylation. TonEBP also recruits RNaseH1 to R-loops through a METTL3 interaction. TonEBP or METTL3 depletion increases R-loop accumulation and reduces cell survival under genotoxic stress.","method":"Single-molecule imaging, biochemical R-loop binding assays, co-immunoprecipitation, METTL3 recruitment assay, domain mapping (RHD), RNaseH1 recruitment, siRNA knockdown, cell survival assays","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — single-molecule imaging plus biochemical reconstitution plus Co-IP plus domain mutagenesis plus functional cell viability assays; multiple orthogonal methods","pmids":["33313823"],"is_preprint":false},{"year":2021,"finding":"PARP1-mediated PARylation of TonEBP is required for its recruitment to sites of R-loop-associated DNA damage induced by camptothecin. TonEBP interacts with PARP1, and loss of TonEBP increases R-loop accumulation and DNA damage and promotes cell death under CPT treatment.","method":"Co-immunoprecipitation, PARylation assays, R-loop detection, siRNA knockdown, cell death assays","journal":"DNA repair","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus PARP1 inhibition plus functional R-loop and cell death readouts, single lab","pmids":["34049076"],"is_preprint":false},{"year":2023,"finding":"EGFR activation induces phosphorylated EZH2 (Ser21) binding to NFAT5 and triggers NFAT5 methylation at K668. This methylation prevents NFAT5 interaction with E3 ligase TRAF6 in the cytoplasm, blocking TRAF6-mediated K63-linked ubiquitination and lysosomal degradation, resulting in NFAT5 protein stabilization, nuclear accumulation, and activation. Methylated NFAT5 upregulates MGMT expression, mediating temozolomide resistance in glioblastoma.","method":"Co-immunoprecipitation, ubiquitination assays, site-directed mutagenesis (K668), reporter assays, orthotopic xenograft and PDX models, MGMT expression analysis","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — biochemical characterization of methylation site, ubiquitination mechanism, in vivo xenograft validation, multiple orthogonal methods","pmids":["37429858"],"is_preprint":false},{"year":2016,"finding":"TonEBP suppresses HO-1 (heme oxygenase-1) expression in M1 macrophages by blocking Nrf2 recruitment to the HO-1 promoter, thereby promoting M1 polarization. TonEBP suppresses IL-10 expression and M2 macrophage phenotype by enhancing chromatin accessibility and Sp1 recruitment to the IL-10 promoter when TonEBP is knocked down.","method":"ChIP, siRNA knockdown, reporter assays, neutralizing antibodies, macrophage polarization assays","journal":"Frontiers in immunology / Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP assays showing direct promoter binding mechanism plus functional reporter and polarization assays, single lab","pmids":["31057560","27160066"],"is_preprint":false},{"year":2020,"finding":"In microglia, TonEBP acts as a transcriptional cofactor for both NF-κB and AP-1; LPS induces assembly of a TonEBP/NF-κB/AP-1/p300 complex. Microglial-specific TonEBP deletion blocks LPS-induced pro-inflammatory cytokine expression, microglial activation, and subsequent neuronal cell death and memory loss. Cerulenin disrupts this complex.","method":"shRNA knockdown, myeloid-specific conditional KO mice, reporter assays, co-immunoprecipitation, LPS challenge, behavioral memory tests","journal":"Journal of neuroinflammation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO in vivo and Co-IP demonstrating complex, single lab","pmids":["33292328"],"is_preprint":false},{"year":2010,"finding":"NFAT5 controls the expression of CD24 in T cells in response to hypertonicity; NFAT5 binds to the Cd24 promoter in response to hyperosmotic stress, facilitating local chromatin derepression and increased CD24 mRNA and protein expression, which is required to sustain T cell expansion under osmostress.","method":"ChIP, chromatin accessibility assay, NFAT5 KO and T cell-specific KO mice, in vitro hypernatremia, flow cytometry","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP with promoter binding plus genetic KO models with in vivo and in vitro functional validation, single lab","pmids":["21037089"],"is_preprint":false},{"year":2015,"finding":"TonEBP binds the PPARγ2 promoter and blocks the epigenetic transition required for its activation, suppressing adipogenesis and insulin signaling. TonEBP reduction permits PPARγ2 epigenetic remodeling, enhanced adipogenesis, and improved insulin response.","method":"ChIP, epigenetic chromatin analysis, reporter assays, knockdown/overexpression, adipogenesis functional assays","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP showing direct promoter occupancy with epigenetic and functional readouts, single lab","pmids":["26042523"],"is_preprint":false},{"year":2016,"finding":"NFAT5 binds a consensus sequence TGGAAGCGTTC in the promoter of Cacna1c (L-type calcium channel α1C) and activates its transcription. siRNA knockdown of Nfat5 suppresses Cacna1c expression and decreases L-type calcium current in neonatal cardiomyocytes; morpholino-mediated knockdown in zebrafish abolishes cacna1c expression and results in non-contractile ventricle, rescued by overexpression of either cacna1c or nfat5.","method":"Promoter binding/reporter assay, siRNA knockdown, electrophysiology (L-type Ca2+ current), zebrafish morpholino knockdown, rescue experiments","journal":"Journal of molecular medicine","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — promoter binding confirmed, electrophysiology, and in vivo zebrafish genetic model with rescue; multiple orthogonal methods","pmids":["27368804"],"is_preprint":false},{"year":2024,"finding":"Aurora kinase B (AURKB) phosphorylates NFAT5, enhancing its protein stability and nuclear translocation, which directly controls AQP4 (aquaporin-4) expression in astrocytes. The AURKB-NFAT5-AQP4 pathway regulates astrocyte swelling and contributes to neuropathic pain in the spinal dorsal horn.","method":"Phosphorylation assays, protein stability assays, nuclear translocation assays, AQP4 promoter reporter, spinal cord neuropathic pain model, selective astrocyte vs. microglia analysis","journal":"Advanced science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mechanistic pathway (AURKB→NFAT5 phosphorylation→AQP4) defined with functional in vivo pain model, single lab","pmids":["38195869"],"is_preprint":false},{"year":2022,"finding":"NLRC3 inhibits NF-κB p65 binding to the NFAT5 promoter by decreasing NF-κB activation and p300 co-activator activity through sequestration of mTOR and p300 in the NLRC3-mTOR-p300 complex, reducing NFAT5-dependent glycolytic gene expression in immunosuppressed macrophages.","method":"Myeloid-specific NLRC3 deletion, co-immunoprecipitation of NLRC3-mTOR-p300 complex, ChIP for p65 at NFAT5 promoter, glycolysis assays","journal":"Molecular therapy","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP demonstrating protein complex, ChIP showing p65 binding, conditional KO, single lab","pmids":["36068919"],"is_preprint":false},{"year":2024,"finding":"Serum amyloid A (SAA) activates NFAT5 expression and activity in macrophages via the TLR2/4-JNK signaling pathway. The SAA-TLR2/4-NFAT5 axis promotes macrophage migration and chemotaxis in an IL-6- and CCL2-dependent manner. Genetic ablation of NFAT5 or TLR2/4 rescues SAA-induced arthritis pathology in mice.","method":"In vitro macrophage stimulation with SAA, TLR2/4 and NFAT5 genetic KO mice, JNK pathway inhibition, migration/chemotaxis assays, intraarticular SAA injection model","journal":"The Journal of clinical investigation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO in vivo with signaling pathway analysis, single lab","pmids":["38426494"],"is_preprint":false}],"current_model":"NFAT5 (TonEBP/OREBP) is a constitutively nuclear, homodimeric Rel-family transcription factor that completely encircles its TonE/ORE DNA target; it is activated by hypertonic stress through a multi-kinase cascade involving c-Abl-mediated phosphorylation at Y143 (enabling PLC-γ1 binding), CDK5-mediated phosphorylation at T135 (driving rapid nuclear import), ATM-mediated phosphorylation at multiple Ser sites, and p38α/ERK/PKC-α signaling acting on its C-terminal transactivation domain, while GSK-3β and SHP-1 phosphatase restrain its activity and RHA inhibits it via the E'F loop; beyond osmostress, NFAT5 serves as a transcriptional cofactor for NF-κB and AP-1 (recruiting p300 to form an enhanceosome), suppresses competing transcription factors (blocking Nrf2 at the HO-1 promoter, blocking epigenetic activation of PPARγ2), recruits DNMT1 to methylate target gene promoters, and in the DNA damage response recognizes R-loops via its Rel homology domain to recruit METTL3 for m6A methylation-dependent R-loop resolution; additionally, EZH2-mediated K668 methylation stabilizes NFAT5 by blocking TRAF6-dependent ubiquitination and lysosomal degradation, and AURKB phosphorylation enhances its stability and nuclear translocation."},"narrative":{"mechanistic_narrative":"NFAT5 (TonEBP/OREBP) is a constitutively nuclear, Rel-family transcription factor that translates osmotic and inflammatory stress into transcriptional programs governing cellular survival and adaptation [PMID:10377394, PMID:11792870]. Unlike calcineurin-regulated NFAT1-4, it carries an NFAT-like Rel homology domain that binds TonE/ORE elements but lacks Fos/Jun cooperativity, and its nuclear localization is calcineurin-independent [PMID:10377394]; structurally it acts as a homodimer that completely encircles its DNA target, conferring kinetic stability to the complex, with C-terminal Rel-homology dimerization required for both DNA binding and proper phosphorylation [PMID:11780147, PMID:12074571]. Hypertonic stress is relayed to NFAT5 through a multi-kinase network acting on distinct steps: c-Abl phosphorylates Y143 to create a PLC-γ1 docking site driving nuclear localization and transactivation [PMID:20080774, PMID:20585028], CDK5 phosphorylates T135 to promote rapid early nuclear import [PMID:21209322], ATM (downstream of c-Abl) phosphorylates C-terminal Ser sites and supports nuclear translocation [PMID:15173573, PMID:15840767, PMID:20585028], and a p38α/ERK/PKC-α axis acts on the osmotically regulated C-terminal transactivation domain [PMID:11792870, PMID:12359721, PMID:25391900], while SHP-1 (dephosphorylating Y143) and GSK-3β restrain activity and RNA helicase A inhibits it via the E'F loop [PMID:16173919, PMID:20351292, PMID:23324178]. Beyond osmoadaptation, NFAT5 is a transcriptional cofactor that recruits p300 to NF-κB and AP-1 to form pro-inflammatory enhanceosomes in macrophages and microglia [PMID:27118681, PMID:33292328], and it operates as an epigenetic repressor by recruiting DNMT1 to methylate target promoters and by blocking the epigenetic activation of PPARγ2 and Nrf2-driven HO-1 [PMID:31387996, PMID:31057560, PMID:27160066, PMID:26042523]. NFAT5 directly activates lineage- and tissue-specific targets including Cacna1c in cardiomyocytes, CD24 in T cells, and AQP4 in astrocytes [PMID:21037089, PMID:27368804, PMID:38195869], and in the DNA damage response it recognizes R-loops through its Rel homology domain to recruit METTL3 and RNaseH1 for m6A-dependent R-loop resolution, an event requiring PARP1-mediated PARylation [PMID:33313823, PMID:34049076]. NFAT5 protein stability is controlled by EZH2-mediated K668 methylation, which blocks TRAF6-dependent K63 ubiquitination and lysosomal degradation, and by AURKB phosphorylation [PMID:37429858, PMID:38195869].","teleology":[{"year":1999,"claim":"Established that NFAT5 is a distinct Rel-family transcription factor with NFAT-like DNA-binding but constitutive, calcineurin-independent nuclear residence, defining it as mechanistically separate from NFAT1-4.","evidence":"DNA-binding and reporter assays, immunofluorescence localization, contact-residue sequence analysis","pmids":["10377394"],"confidence":"High","gaps":["Did not define the activating signal or post-translational regulation","Did not establish target gene repertoire"]},{"year":2002,"claim":"Resolved the structural basis of DNA recognition, showing NFAT5 forms an NF-κB-like homodimer that encircles its TonE target for kinetic stability, and that CRHD-mediated dimerization is required for DNA binding and phosphorylation.","evidence":"X-ray crystallography, EMSA, DNA-binding kinetics, deletion mutagenesis","pmids":["11780147","12074571"],"confidence":"High","gaps":["Did not connect dimerization to upstream signaling","Structure of the transactivation domain not resolved"]},{"year":2002,"claim":"Localized osmotic regulation to the C-terminal transactivation domain controlled by tonicity-driven phosphorylation, implicating p38 MAPK, Fyn, and tyrosine/CK2 kinases as the activating effectors.","evidence":"GAL4-TAD reporter assays, dominant-negative mutants, pharmacological inhibition, Fyn-deficient cells","pmids":["11792870","12359721"],"confidence":"High","gaps":["Did not map specific phosphosites","Did not order kinases into a cascade"]},{"year":2004,"claim":"Connected high-NaCl-induced DNA damage signaling to NFAT5 by showing ATM physically associates with and phosphorylates it at defined Ser sites and supports nuclear translocation, linking genotoxic and osmotic stress responses.","evidence":"Reciprocal Co-IP, S1197A/S1247A/S1367A mutagenesis, ATM-deficient cell reconstitution, fractionation","pmids":["15173573","15840767"],"confidence":"High","gaps":["Did not place ATM relative to other upstream kinases","Mechanism of ATM activation by NaCl not fully defined here"]},{"year":2005,"claim":"Identified parallel non-transcriptional inputs raising NFAT5 abundance and activity, namely 5'-UTR-dependent mRNA stabilization and mitochondrial superoxide enhancing transactivation without affecting nuclear import.","evidence":"Actinomycin D chase, UTR luciferase reporters, ROS-source inhibitors, ORE reporter and target mRNA assays","pmids":["15900024","15769933","16303854"],"confidence":"Medium","gaps":["ROS sensor on NFAT5 not identified","mRNA-stabilizing trans-factors unknown"]},{"year":2006,"claim":"Defined the nucleocytoplasmic shuttling machinery and an inhibitory interactome, showing CRM1-dependent NES-mediated export and identifying RHA (E'F loop) and proteomically a DNA-PK/PARP-1/Hsp90 network as activity modulators.","evidence":"NES mutagenesis, BiFC with CRM1, leptomycin B, domain-mapped Co-IP, MS-based proteomics with EMSA/reporter validation","pmids":["16782704","16173919","17148781"],"confidence":"High","gaps":["Functional roles of many co-purifying proteins not dissected","Mechanism of tonicity-induced RHA dissociation unresolved"]},{"year":2009,"claim":"Established the proximal tyrosine-phosphorylation switch: c-Abl phosphorylates Y143 to recruit PLC-γ1, driving nuclear localization and transactivation, with c-Abl also required for ATM activation.","evidence":"PLC-γ1 null cells, Y143A mutagenesis, reciprocal Co-IP, in vitro kinase assays, imatinib/siRNA, in vivo renal medulla","pmids":["20080774","20585028"],"confidence":"High","gaps":["How PLC-γ1 enhances transactivation mechanistically unclear","Upstream osmosensor for c-Abl not defined"]},{"year":2010,"claim":"Defined opposing positive and negative regulators that fine-tune NFAT5: SHP-1 dephosphorylates Y143 to restrain activity (relieved by NaCl-induced SHP-1 Ser591 inhibition), while p38 isoforms exert opposing (p38α activating, p38δ inhibiting) effects.","evidence":"Genome-wide phosphatase siRNA screen, in vitro phosphatase assay, Co-IP, isoform-specific siRNA, reporter assays","pmids":["20351292","18367666"],"confidence":"High","gaps":["Integration of opposing p38 isoform signals in vivo unclear","How NaCl phosphorylates SHP-1 Ser591 not defined"]},{"year":2011,"claim":"Resolved temporal control and an additional upstream branch: CDK5 phosphorylates T135 for rapid early nuclear import, and a Rac1/OSM scaffold feeds into NFAT5 via PLC-γ1 rather than p38.","evidence":"MS phosphosite mapping, S134A/T135A mutagenesis, CDK5 inhibition, PLC-γ1 null reconstitution, in vivo renal medulla","pmids":["21209322","21712438"],"confidence":"High","gaps":["Coordination of early CDK5 versus late ATM/c-Abl inputs incomplete","Osmosensing event upstream of Rac1/OSM unknown"]},{"year":2013,"claim":"Extended NFAT5 biology beyond osmostress, showing IKKβ-driven NFAT5 promotes thymocyte survival and β-selection osmostress-independently, while GSK-3β suppresses transactivation and is relieved by PKA/PI3K/AKT1.","evidence":"NFAT5-deficient and T cell-specific KO mice, GSK-3β null MEFs, S9A mutant, kinase overexpression, reporter assays","pmids":["24043824","23324178"],"confidence":"Medium","gaps":["Osmostress-independent activation mechanism in thymocytes not fully defined","How GSK-3β suppresses TAD mechanistically unknown"]},{"year":2014,"claim":"Completed the serine/threonine activation branch by placing PKC-α upstream of ERK1/2 (independent of SHP-1) to drive NFAT5 protein and target gene expression in the renal medulla.","evidence":"PKC-α KO mice, siRNA epistasis with ERK2, reporter assays, in vivo renal medulla analysis","pmids":["25391900"],"confidence":"Medium","gaps":["ERK target residues on NFAT5 not mapped","Crosstalk with the c-Abl/PLC-γ1 branch unresolved"]},{"year":2016,"claim":"Defined NFAT5 as a transcriptional cofactor building inflammatory enhanceosomes by recruiting p300 to NF-κB and as an epigenetic repressor blocking Nrf2 at the HO-1 promoter, linking it to macrophage polarization and sepsis.","evidence":"Myeloid-specific KO mice, p300-recruitment-deficient mutants, Co-IP, ChIP, cerulenin disruption, sepsis model","pmids":["27118681","31057560","27160066","20685965"],"confidence":"High","gaps":["Structural basis of p300 recruitment not defined","Generality of enhanceosome across inflammatory genes unclear"]},{"year":2016,"claim":"Demonstrated direct, tissue-specific gene activation by NFAT5 at a defined consensus, establishing it as a transcriptional driver of Cacna1c and L-type calcium current essential for cardiac contractility.","evidence":"Promoter binding/reporter assays, siRNA, electrophysiology, zebrafish morpholino knockdown with cacna1c/nfat5 rescue","pmids":["27368804"],"confidence":"High","gaps":["Cofactor requirements at the Cacna1c promoter not defined","Osmotic dependence of cardiac NFAT5 activity not addressed"]},{"year":2019,"claim":"Established NFAT5 as a recruiter of DNMT1 to methylate and silence target promoters, defining a DNA-methylation-based repressive mechanism controlling adipose beiging and metabolic phenotype.","evidence":"Adipocyte-specific and haploinsufficient mice, ChIP, DNMT1 recruitment, promoter methylation, metabolic phenotyping","pmids":["31387996","26042523"],"confidence":"High","gaps":["How NFAT5 selects DNMT1 target promoters unknown","Reversibility of established methylation marks not addressed"]},{"year":2021,"claim":"Uncovered a non-transcriptional genome-maintenance function in which NFAT5 recognizes R-loops via its Rel homology domain and recruits METTL3 (m6A) and RNaseH1 for R-loop resolution, with PARP1-dependent PARylation enabling recruitment to damage sites.","evidence":"Single-molecule imaging, biochemical R-loop binding, domain-mapped Co-IP, METTL3/RNaseH1 recruitment, PARylation assays, survival assays","pmids":["33313823","34049076"],"confidence":"High","gaps":["Relationship between DNA-binding and R-loop-binding modes unclear","Whether transcriptional and R-loop functions are coupled unknown"]},{"year":2023,"claim":"Defined methylation-controlled protein stability: EGFR-driven phospho-EZH2 methylates NFAT5 at K668, blocking TRAF6-mediated K63 ubiquitination and lysosomal degradation, stabilizing NFAT5 to drive MGMT-dependent temozolomide resistance.","evidence":"Co-IP, ubiquitination assays, K668 mutagenesis, reporter assays, orthotopic xenograft and PDX models","pmids":["37429858"],"confidence":"High","gaps":["Whether K668 methylation interfaces with osmotic activation unknown","Demethylase reversing the mark not identified"]},{"year":2024,"claim":"Extended NFAT5's pathological roles, showing AURKB phosphorylation stabilizes NFAT5 to drive AQP4 and astrocyte swelling in neuropathic pain, and SAA-TLR2/4-JNK signaling activates NFAT5 to promote macrophage chemotaxis in arthritis.","evidence":"Phosphorylation and stability assays, AQP4 reporter, neuropathic pain and SAA-arthritis models, TLR2/4 and NFAT5 KO mice, JNK inhibition","pmids":["38195869","38426494"],"confidence":"Medium","gaps":["AURKB phosphosites on NFAT5 not mapped","Whether JNK acts on NFAT5 protein directly unclear"]},{"year":null,"claim":"How the multiple parallel kinase, phosphatase, methylation, and PARylation inputs are integrated to produce context-specific NFAT5 transcriptional versus genome-maintenance outputs remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model coordinating osmotic, inflammatory, and DNA-damage activation modes","Structural basis distinguishing TonE-DNA binding from R-loop recognition unknown","Selectivity determinants for activating versus repressive (DNMT1-recruiting) target promoters undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,3,23,24,31,33]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,1,2,33]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[23,24,26,30]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,7,10,18]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[10,28]}],"pathway":[{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[0,3,4,13,18]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[23,24,31,33]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[21,23,25,29,30,36]},{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[5,26,27]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[14,24,29,31,32]}],"complexes":["TonEBP/NF-κB/p300 enhanceosome","TonEBP/NF-κB/AP-1/p300 complex"],"partners":["PLCG1","ABL1","ATM","CDK5","PTPN6","METTL3","PARP1","EZH2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"O94916","full_name":"Nuclear factor of activated T-cells 5","aliases":["T-cell transcription factor NFAT5","Tonicity-responsive enhancer-binding protein","TonE-binding protein","TonEBP"],"length_aa":1531,"mass_kda":165.8,"function":"Transcription factor involved, among others, in the transcriptional regulation of osmoprotective and inflammatory genes. Binds the DNA consensus sequence 5'-[ACT][AG]TGGAAA[CAT]A[TA][ATC][CA][ATG][GT][GAC][CG][CT]-3' (PubMed:10377394). Mediates the transcriptional response to hypertonicity (PubMed:10051678). Positively regulates the transcription of LCN2 and S100A4 genes; optimal transactivation of these genes requires the presence of DDX5/DDX17 (PubMed:22266867). Also involved in the DNA damage response by preventing formation of R-loops; R-loops are composed of a DNA:RNA hybrid and the associated non-template single-stranded DNA (PubMed:34049076)","subcellular_location":"Nucleus; Cytoplasm; Chromosome","url":"https://www.uniprot.org/uniprotkb/O94916/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/NFAT5","classification":"Not Classified","n_dependent_lines":15,"n_total_lines":1208,"dependency_fraction":0.012417218543046357},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/NFAT5","total_profiled":1310},"omim":[{"mim_id":"621029","title":"RING FINGER PROTEIN 183; RNF183","url":"https://www.omim.org/entry/621029"},{"mim_id":"604708","title":"NUCLEAR FACTOR OF ACTIVATED T CELLS 5; NFAT5","url":"https://www.omim.org/entry/604708"},{"mim_id":"603423","title":"PR DOMAIN-CONTAINING PROTEIN 1; PRDM1","url":"https://www.omim.org/entry/603423"},{"mim_id":"602958","title":"SERUM/GLUCOCORTICOID-REGULATED KINASE 1; SGK1","url":"https://www.omim.org/entry/602958"},{"mim_id":"600490","title":"NUCLEAR FACTOR OF ACTIVATED T CELLS, CYTOPLASMIC, CALCINEURIN-DEPENDENT 2; NFATC2","url":"https://www.omim.org/entry/600490"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Nucleoplasm","reliability":"Enhanced"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in many","driving_tissues":[],"url":"https://www.proteinatlas.org/search/NFAT5"},"hgnc":{"alias_symbol":["TONEBP","KIAA0827","NFATL1","OREBP","NFATZ","NF-AT5"],"prev_symbol":[]},"alphafold":{"accession":"O94916","domains":[{"cath_id":"2.60.40.340","chopping":"277-441","consensus_level":"high","plddt":94.6327,"start":277,"end":441},{"cath_id":"2.60.40.10","chopping":"448-547","consensus_level":"high","plddt":93.8625,"start":448,"end":547}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O94916","model_url":"https://alphafold.ebi.ac.uk/files/AF-O94916-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O94916-F1-predicted_aligned_error_v6.png","plddt_mean":44.59},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=NFAT5","jax_strain_url":"https://www.jax.org/strain/search?query=NFAT5"},"sequence":{"accession":"O94916","fasta_url":"https://rest.uniprot.org/uniprotkb/O94916.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O94916/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O94916"}},"corpus_meta":[{"pmid":"10377394","id":"PMC_10377394","title":"NFAT5, a constitutively nuclear NFAT protein that does not cooperate with Fos and Jun.","date":"1999","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/10377394","citation_count":318,"is_preprint":false},{"pmid":"12138186","id":"PMC_12138186","title":"TonEBP/NFAT5 stimulates transcription of HSP70 in response to hypertonicity.","date":"2002","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12138186","citation_count":175,"is_preprint":false},{"pmid":"11046013","id":"PMC_11046013","title":"The NFAT-related protein NFATL1 (TonEBP/NFAT5) is induced upon T cell activation in a calcineurin-dependent manner.","date":"2000","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/11046013","citation_count":137,"is_preprint":false},{"pmid":"12359721","id":"PMC_12359721","title":"Fyn and p38 signaling are both required for maximal hypertonic activation of the osmotic response element-binding protein/tonicity-responsive enhancer-binding protein (OREBP/TonEBP).","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12359721","citation_count":128,"is_preprint":false},{"pmid":"10995747","id":"PMC_10995747","title":"The TonE/TonEBP pathway mediates tonicity-responsive regulation of UT-A urea transporter expression.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10995747","citation_count":119,"is_preprint":false},{"pmid":"11792870","id":"PMC_11792870","title":"Activity of the TonEBP/OREBP transactivation domain varies directly with extracellular NaCl concentration.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/11792870","citation_count":118,"is_preprint":false},{"pmid":"12194010","id":"PMC_12194010","title":"TonEBP transcriptional activator in the cellular response to increased osmolality.","date":"2002","source":"Pflugers Archiv : European journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/12194010","citation_count":114,"is_preprint":false},{"pmid":"11780147","id":"PMC_11780147","title":"Structure of a TonEBP-DNA complex reveals DNA encircled by a transcription factor.","date":"2002","source":"Nature structural biology","url":"https://pubmed.ncbi.nlm.nih.gov/11780147","citation_count":104,"is_preprint":false},{"pmid":"15173573","id":"PMC_15173573","title":"ATM, a DNA damage-inducible kinase, contributes to activation by high NaCl of the transcription factor TonEBP/OREBP.","date":"2004","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/15173573","citation_count":96,"is_preprint":false},{"pmid":"25172826","id":"PMC_25172826","title":"Extracellular osmolarity regulates matrix homeostasis in the intervertebral disc and articular cartilage: evolving role of TonEBP.","date":"2014","source":"Matrix biology : journal of the International Society for Matrix Biology","url":"https://pubmed.ncbi.nlm.nih.gov/25172826","citation_count":96,"is_preprint":false},{"pmid":"30873159","id":"PMC_30873159","title":"Role of NFAT5 in the Immune System and Pathogenesis of Autoimmune Diseases.","date":"2019","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30873159","citation_count":90,"is_preprint":false},{"pmid":"21998140","id":"PMC_21998140","title":"Tonicity-independent regulation of the osmosensitive transcription factor TonEBP (NFAT5).","date":"2011","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/21998140","citation_count":90,"is_preprint":false},{"pmid":"20685965","id":"PMC_20685965","title":"Osmoprotective transcription factor NFAT5/TonEBP modulates nuclear factor-kappaB activity.","date":"2010","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/20685965","citation_count":89,"is_preprint":false},{"pmid":"16772300","id":"PMC_16772300","title":"TonEBP/OREBP is a regulator of nucleus pulposus cell function and survival in the intervertebral disc.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16772300","citation_count":87,"is_preprint":false},{"pmid":"17371162","id":"PMC_17371162","title":"MEK/ERK signaling controls osmoregulation of nucleus pulposus cells of the intervertebral disc by transactivation of TonEBP/OREBP.","date":"2007","source":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","url":"https://pubmed.ncbi.nlm.nih.gov/17371162","citation_count":85,"is_preprint":false},{"pmid":"16734761","id":"PMC_16734761","title":"How tonicity regulates genes: story of TonEBP transcriptional activator.","date":"2006","source":"Acta physiologica (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/16734761","citation_count":80,"is_preprint":false},{"pmid":"15347663","id":"PMC_15347663","title":"Osmotic response element-binding protein (OREBP) is an essential regulator of the urine concentrating mechanism.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15347663","citation_count":77,"is_preprint":false},{"pmid":"33313823","id":"PMC_33313823","title":"TonEBP recognizes R-loops and initiates m6A RNA methylation for R-loop resolution.","date":"2021","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/33313823","citation_count":74,"is_preprint":false},{"pmid":"20852262","id":"PMC_20852262","title":"Tonicity-responsive microRNAs contribute to the maximal induction of osmoregulatory transcription factor OREBP in response to high-NaCl hypertonicity.","date":"2010","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/20852262","citation_count":73,"is_preprint":false},{"pmid":"32157251","id":"PMC_32157251","title":"The evolving role of TonEBP as an immunometabolic stress protein.","date":"2020","source":"Nature reviews. Nephrology","url":"https://pubmed.ncbi.nlm.nih.gov/32157251","citation_count":66,"is_preprint":false},{"pmid":"15900024","id":"PMC_15900024","title":"High NaCl increases TonEBP/OREBP mRNA and protein by stabilizing its mRNA.","date":"2005","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/15900024","citation_count":61,"is_preprint":false},{"pmid":"36068919","id":"PMC_36068919","title":"NLRC3 expression in macrophage impairs glycolysis and host immune defense by modulating the NF-κB-NFAT5 complex during septic immunosuppression.","date":"2022","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/36068919","citation_count":60,"is_preprint":false},{"pmid":"12538727","id":"PMC_12538727","title":"Silencing of TonEBP/NFAT5 transcriptional activator by RNA interference.","date":"2003","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/12538727","citation_count":57,"is_preprint":false},{"pmid":"12729611","id":"PMC_12729611","title":"The role of NFAT5/TonEBP in establishing an optimal intracellular environment.","date":"2003","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/12729611","citation_count":57,"is_preprint":false},{"pmid":"16782704","id":"PMC_16782704","title":"Regulation of nucleocytoplasmic trafficking of transcription factor OREBP/TonEBP/NFAT5.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16782704","citation_count":56,"is_preprint":false},{"pmid":"25152734","id":"PMC_25152734","title":"NFAT5-mediated expression of S100A4 contributes to proliferation and migration of renal carcinoma cells.","date":"2014","source":"Frontiers in physiology","url":"https://pubmed.ncbi.nlm.nih.gov/25152734","citation_count":56,"is_preprint":false},{"pmid":"15769933","id":"PMC_15769933","title":"Increased reactive oxygen species contribute to high NaCl-induced activation of the osmoregulatory transcription factor TonEBP/OREBP.","date":"2005","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/15769933","citation_count":55,"is_preprint":false},{"pmid":"30949179","id":"PMC_30949179","title":"Regulation of Inflammatory Functions of Macrophages and T Lymphocytes by NFAT5.","date":"2019","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30949179","citation_count":54,"is_preprint":false},{"pmid":"11934689","id":"PMC_11934689","title":"Mouse TonEBP-NFAT5: expression in early development and alternative splicing.","date":"2002","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/11934689","citation_count":54,"is_preprint":false},{"pmid":"27118681","id":"PMC_27118681","title":"LPS-induced NFκB enhanceosome requires TonEBP/NFAT5 without DNA binding.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27118681","citation_count":53,"is_preprint":false},{"pmid":"37709986","id":"PMC_37709986","title":"Activation of the transcription factor NFAT5 in the tumor microenvironment enforces CD8+ T cell exhaustion.","date":"2023","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/37709986","citation_count":52,"is_preprint":false},{"pmid":"21209002","id":"PMC_21209002","title":"TonEBP stimulates multiple cellular pathways for adaptation to hypertonic stress: organic osmolyte-dependent and -independent pathways.","date":"2011","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/21209002","citation_count":52,"is_preprint":false},{"pmid":"23324178","id":"PMC_23324178","title":"Inhibitory phosphorylation of GSK-3β by AKT, PKA, and PI3K contributes to high NaCl-induced activation of the transcription factor NFAT5 (TonEBP/OREBP).","date":"2013","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/23324178","citation_count":51,"is_preprint":false},{"pmid":"30982460","id":"PMC_30982460","title":"HIF1A and NFAT5 coordinate Na+-boosted antibacterial defense via enhanced autophagy and autolysosomal targeting.","date":"2019","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/30982460","citation_count":50,"is_preprint":false},{"pmid":"16303854","id":"PMC_16303854","title":"Mitochondrial reactive oxygen species contribute to high NaCl-induced activation of the transcription factor TonEBP/OREBP.","date":"2005","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/16303854","citation_count":49,"is_preprint":false},{"pmid":"37088425","id":"PMC_37088425","title":"Macrophage transcription factor TonEBP promotes systemic lupus erythematosus and kidney injury via damage-induced signaling pathways.","date":"2023","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/37088425","citation_count":48,"is_preprint":false},{"pmid":"22934063","id":"PMC_22934063","title":"NFAT5 expression in bone marrow-derived cells enhances atherosclerosis and drives macrophage migration.","date":"2012","source":"Frontiers in physiology","url":"https://pubmed.ncbi.nlm.nih.gov/22934063","citation_count":48,"is_preprint":false},{"pmid":"21037089","id":"PMC_21037089","title":"NFAT5 regulates T lymphocyte homeostasis and CD24-dependent T cell expansion under pathologic hypernatremia.","date":"2010","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/21037089","citation_count":45,"is_preprint":false},{"pmid":"31387996","id":"PMC_31387996","title":"TonEBP/NFAT5 promotes obesity and insulin resistance by epigenetic suppression of white adipose tissue beiging.","date":"2019","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/31387996","citation_count":43,"is_preprint":false},{"pmid":"11952228","id":"PMC_11952228","title":"Adaptation of kidney medulla to hypertonicity: role of the transcription factor TonEBP.","date":"2002","source":"International review of cytology","url":"https://pubmed.ncbi.nlm.nih.gov/11952228","citation_count":43,"is_preprint":false},{"pmid":"26299924","id":"PMC_26299924","title":"NFAT5 promotes proliferation and migration of lung adenocarcinoma cells in part through regulating AQP5 expression.","date":"2015","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/26299924","citation_count":43,"is_preprint":false},{"pmid":"19138132","id":"PMC_19138132","title":"Osmolarity and intracellular calcium regulate aquaporin2 expression through TonEBP in nucleus pulposus cells of the intervertebral disc.","date":"2009","source":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","url":"https://pubmed.ncbi.nlm.nih.gov/19138132","citation_count":41,"is_preprint":false},{"pmid":"35351860","id":"PMC_35351860","title":"Bone marrow mesenchymal stem cell-derived exosomal microRNA-381-3p alleviates vascular calcification in chronic kidney disease by targeting NFAT5.","date":"2022","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/35351860","citation_count":40,"is_preprint":false},{"pmid":"15840767","id":"PMC_15840767","title":"Ataxia telangiectasia-mutated, a DNA damage-inducible kinase, contributes to high NaCl-induced nuclear localization of transcription factor TonEBP/OREBP.","date":"2005","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/15840767","citation_count":40,"is_preprint":false},{"pmid":"17148781","id":"PMC_17148781","title":"Proteomic identification of proteins associated with the osmoregulatory transcription factor TonEBP/OREBP: functional effects of Hsp90 and PARP-1.","date":"2006","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/17148781","citation_count":38,"is_preprint":false},{"pmid":"25044064","id":"PMC_25044064","title":"The xanthine oxidase-NFAT5 pathway regulates macrophage activation and TLR-induced inflammatory arthritis.","date":"2014","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/25044064","citation_count":38,"is_preprint":false},{"pmid":"12074571","id":"PMC_12074571","title":"Dimerization is required for phosphorylation and DNA binding of TonEBP/NFAT5.","date":"2002","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/12074571","citation_count":38,"is_preprint":false},{"pmid":"15226152","id":"PMC_15226152","title":"Maturation of TonEBP expression in developing rat kidney.","date":"2004","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/15226152","citation_count":36,"is_preprint":false},{"pmid":"19146830","id":"PMC_19146830","title":"Hypertonic induction of COX2 expression requires TonEBP/NFAT5 in renal epithelial cells.","date":"2009","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/19146830","citation_count":35,"is_preprint":false},{"pmid":"20080774","id":"PMC_20080774","title":"Phospholipase C-gamma1 is involved in signaling the activation by high NaCl of the osmoprotective transcription factor TonEBP/OREBP.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/20080774","citation_count":35,"is_preprint":false},{"pmid":"31343932","id":"PMC_31343932","title":"MiR-361-3p/Nfat5 Signaling Axis Controls Cementoblast Differentiation.","date":"2019","source":"Journal of dental research","url":"https://pubmed.ncbi.nlm.nih.gov/31343932","citation_count":33,"is_preprint":false},{"pmid":"18367666","id":"PMC_18367666","title":"MKP-1 inhibits high NaCl-induced activation of p38 but does not inhibit the activation of TonEBP/OREBP: opposite roles of p38alpha and p38delta.","date":"2008","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/18367666","citation_count":33,"is_preprint":false},{"pmid":"21712438","id":"PMC_21712438","title":"Rac1/osmosensing scaffold for MEKK3 contributes via phospholipase C-gamma1 to activation of the osmoprotective transcription factor NFAT5.","date":"2011","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/21712438","citation_count":33,"is_preprint":false},{"pmid":"20585028","id":"PMC_20585028","title":"c-Abl mediates high NaCl-induced phosphorylation and activation of the transcription factor TonEBP/OREBP.","date":"2010","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/20585028","citation_count":32,"is_preprint":false},{"pmid":"19052532","id":"PMC_19052532","title":"Interstitial tonicity controls TonEBP expression in the renal medulla.","date":"2008","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/19052532","citation_count":31,"is_preprint":false},{"pmid":"21209322","id":"PMC_21209322","title":"High NaCl-induced activation of CDK5 increases phosphorylation of the osmoprotective transcription factor TonEBP/OREBP at threonine 135, which contributes to its rapid nuclear localization.","date":"2011","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/21209322","citation_count":31,"is_preprint":false},{"pmid":"23180003","id":"PMC_23180003","title":"NFAT5-dependent expression of AQP4 in astrocytes.","date":"2012","source":"Cellular and molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/23180003","citation_count":31,"is_preprint":false},{"pmid":"27479742","id":"PMC_27479742","title":"Context-dependent regulation of Th17-associated genes and IFNγ expression by the transcription factor NFAT5.","date":"2016","source":"Immunology and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/27479742","citation_count":31,"is_preprint":false},{"pmid":"11350742","id":"PMC_11350742","title":"Amino acid depletion activates TonEBP and sodium-coupled inositol transport.","date":"2001","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/11350742","citation_count":30,"is_preprint":false},{"pmid":"30900402","id":"PMC_30900402","title":"miR-194 suppresses high glucose-induced non-small cell lung cancer cell progression by targeting NFAT5.","date":"2019","source":"Thoracic cancer","url":"https://pubmed.ncbi.nlm.nih.gov/30900402","citation_count":29,"is_preprint":false},{"pmid":"24043824","id":"PMC_24043824","title":"NFAT5 induction by the pre-T-cell receptor serves as a selective survival signal in T-lymphocyte development.","date":"2013","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/24043824","citation_count":28,"is_preprint":false},{"pmid":"15774462","id":"PMC_15774462","title":"Transgenic mice expressing dominant-negative osmotic-response element-binding protein (OREBP) in lens exhibit fiber cell elongation defect associated with increased DNA breaks.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15774462","citation_count":27,"is_preprint":false},{"pmid":"20351292","id":"PMC_20351292","title":"Contribution of SHP-1 protein tyrosine phosphatase to osmotic regulation of the transcription factor TonEBP/OREBP.","date":"2010","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/20351292","citation_count":26,"is_preprint":false},{"pmid":"16926446","id":"PMC_16926446","title":"Sequential expression of NKCC2, TonEBP, aldose reductase, and urea transporter-A in developing mouse kidney.","date":"2006","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/16926446","citation_count":26,"is_preprint":false},{"pmid":"27235345","id":"PMC_27235345","title":"Inflammatory signals induce the expression of tonicity-responsive enhancer binding protein (TonEBP) in microglia.","date":"2016","source":"Journal of neuroimmunology","url":"https://pubmed.ncbi.nlm.nih.gov/27235345","citation_count":26,"is_preprint":false},{"pmid":"31961823","id":"PMC_31961823","title":"Arp2/3 inactivation causes intervertebral disc and cartilage degeneration with dysregulated TonEBP-mediated osmoadaptation.","date":"2020","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/31961823","citation_count":26,"is_preprint":false},{"pmid":"38195869","id":"PMC_38195869","title":"Inhibition of NFAT5-Dependent Astrocyte Swelling Alleviates Neuropathic Pain.","date":"2024","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/38195869","citation_count":25,"is_preprint":false},{"pmid":"37429858","id":"PMC_37429858","title":"Lysine methylation promotes NFAT5 activation and determines temozolomide efficacy in glioblastoma.","date":"2023","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/37429858","citation_count":25,"is_preprint":false},{"pmid":"20041176","id":"PMC_20041176","title":"Inducible nucleosome depletion at OREBP-binding-sites by hypertonic stress.","date":"2009","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/20041176","citation_count":25,"is_preprint":false},{"pmid":"28360221","id":"PMC_28360221","title":"NFAT5 and SLC4A10 Loci Associate with Plasma Osmolality.","date":"2017","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/28360221","citation_count":25,"is_preprint":false},{"pmid":"27160066","id":"PMC_27160066","title":"TonEBP suppresses IL-10-mediated immunomodulation.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27160066","citation_count":24,"is_preprint":false},{"pmid":"30391952","id":"PMC_30391952","title":"NFAT5 Has a Job in the Brain.","date":"2018","source":"Developmental neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/30391952","citation_count":24,"is_preprint":false},{"pmid":"25391900","id":"PMC_25391900","title":"PKC-α contributes to high NaCl-induced activation of NFAT5 (TonEBP/OREBP) through MAPK ERK1/2.","date":"2014","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/25391900","citation_count":24,"is_preprint":false},{"pmid":"32901097","id":"PMC_32901097","title":"NFAT5 promotes oral squamous cell carcinoma progression in a hyperosmotic environment.","date":"2020","source":"Laboratory investigation; a journal of technical methods and pathology","url":"https://pubmed.ncbi.nlm.nih.gov/32901097","citation_count":24,"is_preprint":false},{"pmid":"36934264","id":"PMC_36934264","title":"Exosomal MFI2-AS1 sponge miR-107 promotes non-small cell lung cancer progression through NFAT5.","date":"2023","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/36934264","citation_count":24,"is_preprint":false},{"pmid":"34049076","id":"PMC_34049076","title":"PARP1-mediated PARylation of TonEBP prevents R-loop-associated DNA damage.","date":"2021","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/34049076","citation_count":23,"is_preprint":false},{"pmid":"19369291","id":"PMC_19369291","title":"Expression and function of NFAT5 in medullary thick ascending limb (mTAL) cells.","date":"2009","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/19369291","citation_count":23,"is_preprint":false},{"pmid":"38426494","id":"PMC_38426494","title":"Serum amyloid A expression in liver promotes synovial macrophage activation and chronic arthritis via NFAT5.","date":"2024","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/38426494","citation_count":22,"is_preprint":false},{"pmid":"33015193","id":"PMC_33015193","title":"Potential Role of Gene Regulator NFAT5 in the Pathogenesis of Diabetes Mellitus.","date":"2020","source":"Journal of diabetes research","url":"https://pubmed.ncbi.nlm.nih.gov/33015193","citation_count":22,"is_preprint":false},{"pmid":"28798347","id":"PMC_28798347","title":"TonEBP/NFAT5 haploinsufficiency attenuates hippocampal inflammation in high-fat diet/streptozotocin-induced diabetic mice.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28798347","citation_count":22,"is_preprint":false},{"pmid":"28446591","id":"PMC_28446591","title":"NFAT5-sensitive Orai1 expression and store-operated Ca2+ entry in megakaryocytes.","date":"2017","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/28446591","citation_count":21,"is_preprint":false},{"pmid":"11292634","id":"PMC_11292634","title":"Urea inhibits hypertonicity-inducible TonEBP expression and action.","date":"2001","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/11292634","citation_count":21,"is_preprint":false},{"pmid":"27368804","id":"PMC_27368804","title":"NFAT5-mediated CACNA1C expression is critical for cardiac electrophysiological development and maturation.","date":"2016","source":"Journal of molecular medicine (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/27368804","citation_count":21,"is_preprint":false},{"pmid":"22935419","id":"PMC_22935419","title":"NFAT5 regulates the canonical Wnt pathway and is required for cardiomyogenic differentiation.","date":"2012","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/22935419","citation_count":21,"is_preprint":false},{"pmid":"16173919","id":"PMC_16173919","title":"TonEBP is inhibited by RNA helicase A via interaction involving the E'F loop.","date":"2006","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/16173919","citation_count":21,"is_preprint":false},{"pmid":"19225051","id":"PMC_19225051","title":"EGF receptor signaling is involved in expression of osmoprotective TonEBP target gene aldose reductase under hypertonic conditions.","date":"2009","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/19225051","citation_count":20,"is_preprint":false},{"pmid":"30293684","id":"PMC_30293684","title":"NFAT5 promotes in vivo development of murine melanoma metastasis.","date":"2018","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/30293684","citation_count":20,"is_preprint":false},{"pmid":"19351952","id":"PMC_19351952","title":"Brx shines a light on the route from hyperosmolarity to NFAT5.","date":"2009","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/19351952","citation_count":20,"is_preprint":false},{"pmid":"24990896","id":"PMC_24990896","title":"Regulation of (pro)renin receptor expression in mIMCD via the GSK-3β-NFAT5-SIRT-1 signaling pathway.","date":"2014","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/24990896","citation_count":20,"is_preprint":false},{"pmid":"32499518","id":"PMC_32499518","title":"TonEBP in dendritic cells mediates pro-inflammatory maturation and Th1/Th17 responses.","date":"2020","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/32499518","citation_count":19,"is_preprint":false},{"pmid":"11880333","id":"PMC_11880333","title":"Rottlerin inhibits tonicity-dependent expression and action of TonEBP in a PKCdelta-independent fashion.","date":"2002","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/11880333","citation_count":19,"is_preprint":false},{"pmid":"31301300","id":"PMC_31301300","title":"NFAT5/TonEBP controls early acquisition of notochord phenotypic markers, collagen composition, and sonic hedgehog signaling during mouse intervertebral disc embryogenesis.","date":"2019","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/31301300","citation_count":19,"is_preprint":false},{"pmid":"32896986","id":"PMC_32896986","title":"Genistein-Calcitriol Mitigates Hyperosmotic Stress-Induced TonEBP, CFTR Dysfunction, VDR Degradation and Inflammation in Dry Eye Disease.","date":"2020","source":"Clinical and translational science","url":"https://pubmed.ncbi.nlm.nih.gov/32896986","citation_count":19,"is_preprint":false},{"pmid":"31057560","id":"PMC_31057560","title":"TonEBP Suppresses the HO-1 Gene by Blocking Recruitment of Nrf2 to Its Promoter.","date":"2019","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31057560","citation_count":19,"is_preprint":false},{"pmid":"26042523","id":"PMC_26042523","title":"TonEBP suppresses adipogenesis and insulin sensitivity by blocking epigenetic transition of PPARγ2.","date":"2015","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/26042523","citation_count":18,"is_preprint":false},{"pmid":"33292328","id":"PMC_33292328","title":"Microglial TonEBP mediates LPS-induced inflammation and memory loss as transcriptional cofactor for NF-κB and AP-1.","date":"2020","source":"Journal of neuroinflammation","url":"https://pubmed.ncbi.nlm.nih.gov/33292328","citation_count":18,"is_preprint":false},{"pmid":"25520667","id":"PMC_25520667","title":"TonEBP/NFAT5 regulates ACTBL2 expression in biomechanically activated vascular smooth muscle cells.","date":"2014","source":"Frontiers in physiology","url":"https://pubmed.ncbi.nlm.nih.gov/25520667","citation_count":18,"is_preprint":false},{"pmid":"30745821","id":"PMC_30745821","title":"NFAT5 is Regulated by p53/miR-27a Signal Axis and Promotes Mouse Ovarian Granulosa Cells Proliferation.","date":"2019","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30745821","citation_count":18,"is_preprint":false},{"pmid":"31801906","id":"PMC_31801906","title":"Osteoprotective action of low-salt diet requires myeloid cell-derived NFAT5.","date":"2019","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/31801906","citation_count":18,"is_preprint":false},{"pmid":"31883300","id":"PMC_31883300","title":"NFAT5 promotes arteriogenesis via MCP-1-dependent monocyte recruitment.","date":"2019","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31883300","citation_count":17,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":52482,"output_tokens":9682,"usd":0.151338,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":19959,"output_tokens":6208,"usd":0.127498,"stage2_stop_reason":"end_turn"},"total_usd":0.278836,"stage1_batch_id":"msgbatch_013a8chtv3AWyTqv4z4sEF4C","stage2_batch_id":"msgbatch_01AHsuW63vinsvuTgzmQ3n62","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1999,\n      \"finding\": \"NFAT5 contains an NFAT-like Rel homology domain, binds DNA sequences similar to NFAT1-4 target sites, but lacks the majority of Fos/Jun contact residues and does not bind cooperatively with Fos and Jun to DNA. Unlike NFAT1-4, NFAT5 is constitutively nuclear and its nuclear localization is not regulated by calcineurin-mediated dephosphorylation.\",\n      \"method\": \"DNA binding assays, co-transfection/reporter assays, immunofluorescence localization, sequence analysis of contact residues\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — multiple orthogonal biochemical methods (DNA binding, reporter assay, localization) in a foundational study; widely replicated across subsequent literature\",\n      \"pmids\": [\"10377394\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Crystal structure of TonEBP/NFAT5 Rel homology domain bound to DNA reveals that TonEBP adopts an NF-κB-like homodimeric structure and completely encircles its TonE DNA target, providing increased kinetic stability of the DNA complex.\",\n      \"method\": \"X-ray crystallography, electrophoretic mobility shift assay (EMSA), biochemical DNA-binding kinetics\",\n      \"journal\": \"Nature structural biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure with biochemical validation of DNA encirclement mechanism\",\n      \"pmids\": [\"11780147\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Dimerization of TonEBP via the C-terminus of the Rel homology domain (CRHD) is required for DNA binding and proper phosphorylation (especially under hypertonic conditions); deletion of the CRHD abolishes DNA binding and eliminates dominant-negative activity.\",\n      \"method\": \"Biochemical dimerization assays, deletion mutagenesis, DNA binding assays, phosphorylation analysis\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct mutagenesis and functional readouts in a single focused study\",\n      \"pmids\": [\"12074571\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"The C-terminal transactivation domain (TAD; 983 C-terminal amino acids) of TonEBP/OREBP is osmotically regulated at the post-translational level, with activity decreasing >80% at low osmolality and increasing 8-fold at high NaCl, dependent on tonicity-driven phosphorylation. Tyrosine kinase inhibitor herbimycin and CK2 inhibitor DRB reduce TAD activity, implicating these kinases.\",\n      \"method\": \"GAL4-TAD fusion reporter assay in HepG2 cells, pharmacological kinase inhibition\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean reporter assay with multiple inhibitors in one study, single lab\",\n      \"pmids\": [\"11792870\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"p38 MAPK and Fyn tyrosine kinase are both required for maximal hypertonic activation of OREBP/TonEBP; the transactivation domain is the target of p38- and Fyn-mediated activation. Combined inhibition of p38 in Fyn-deficient cells almost completely abolishes hypertonic ORE reporter induction.\",\n      \"method\": \"Dominant-negative mutants, pharmacological inhibition (SB203580), Fyn-deficient cells, ORE reporter assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic (DN mutants, KO cells) and pharmacological approaches with epistasis analysis, replicated across multiple conditions\",\n      \"pmids\": [\"12359721\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"ATM kinase, activated by high NaCl-induced DNA damage via autophosphorylation at Ser-1981, contributes to TonEBP/OREBP activation. TonEBP/OREBP physically associates with ATM (reciprocal co-IP), ATM phosphorylates TonEBP at consensus sites (Ser-1197, Ser-1247, Ser-1367), and mutation of these sites reduces TonEBP transcriptional activity.\",\n      \"method\": \"Co-immunoprecipitation, site-directed mutagenesis (S1197A, S1247A, S1367A), ATM-deficient (AT) cells, wortmannin inhibition, EMSA supershift\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — reciprocal Co-IP, mutagenesis of phosphorylation sites, genetic reconstitution in AT cells, multiple orthogonal methods\",\n      \"pmids\": [\"15173573\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"High NaCl stabilizes TonEBP/OREBP mRNA (via its 5'-UTR, not the 3'-UTR), which accounts for the increase in mRNA abundance without requiring increased transcription.\",\n      \"method\": \"Actinomycin D chase assay, luciferase reporters containing 5'- and 3'-UTR fragments\",\n      \"journal\": \"American journal of physiology. Renal physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct mRNA stability measurement plus UTR reporter assays, single lab\",\n      \"pmids\": [\"15900024\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"ATM kinase also contributes to high NaCl-induced nuclear translocation of TonEBP/OREBP; nuclear localization of TonEBP and its N-terminal Rel homology domain is reduced in ATM-deficient (AT) cells and restored by reconstitution with functional ATM.\",\n      \"method\": \"Western blot of nuclear/cytoplasmic fractions, ATM-deficient cells, wortmannin inhibition, genetic reconstitution\",\n      \"journal\": \"American journal of physiology. Renal physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic complementation in AT cells, fractionation assay, single lab\",\n      \"pmids\": [\"15840767\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"High NaCl increases reactive oxygen species (specifically superoxide from mitochondrial complexes I and III), which contribute to TonEBP/OREBP activation by increasing its transactivating activity but not nuclear translocation.\",\n      \"method\": \"Pharmacological inhibitors (rotenone, myxothiazol, NAC, MnTBAP), ORE/TonE reporter assay, BGT1 mRNA measurement\",\n      \"journal\": \"American journal of physiology. Renal physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple inhibitors targeting specific ROS sources, functional reporter and mRNA readouts, single lab\",\n      \"pmids\": [\"15769933\", \"16303854\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"TonEBP is physically associated in vivo with RNA helicase A (RHA), which binds the E'F loop of the DNA-binding domain. Overexpression of RHA inhibits TonEBP activity; elevated tonicity decreases the TonEBP-RHA interaction, suggesting RHA dissociation is a mechanism for TonEBP activation.\",\n      \"method\": \"Co-immunoprecipitation, domain mapping, overexpression, reporter assays\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — Co-IP with domain mapping and functional assay, single lab\",\n      \"pmids\": [\"16173919\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"TonEBP/OREBP nuclear export under isotonic conditions is mediated by a CRM1-dependent leucine-rich nuclear export sequence (NES) in the N-terminus; hypotonicity-induced nuclear export additionally requires a distinct auxiliary export domain. CRM1 physically interacts with TonEBP, demonstrated by bimolecular fluorescence complementation.\",\n      \"method\": \"Immunocytochemistry, GFP fusions, site-directed mutagenesis of NES, bimolecular fluorescence complementation assay, leptomycin B treatment\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — mutagenesis, protein-protein interaction assay, multiple constructs, clear functional domain mapping\",\n      \"pmids\": [\"16782704\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Proteomic analysis identified 14 proteins physically associated with TonEBP/OREBP in nuclei under high NaCl conditions, including DNA-PK (catalytic subunit and Ku86), RNA helicases (RHA, nucleolar RNA helicase II/Gu, DEAD-box p72), several hnRNPs and snRNPs, Hsp90β, Hsc70, and PARP-1. PARP-1 reduces TonEBP transcriptional and transactivating activities, while Hsp90 enhances them and sustains TonEBP protein abundance.\",\n      \"method\": \"Stable expression of N-terminal TonEBP fragment, immunoprecipitation, mass spectrometry, Western blot confirmation, EMSA, reporter assays\",\n      \"journal\": \"American journal of physiology. Renal physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — MS-based proteomics confirmed by Western, EMSA, and functional reporter assays with multiple interactors validated\",\n      \"pmids\": [\"17148781\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"p38α and p38δ isoforms have opposing effects on TonEBP/OREBP activity: p38α increases TonEBP activity while p38δ decreases it. Overexpression of MKP-1 inhibits both p38 isoforms but has no net effect on TonEBP/OREBP activity due to these opposing actions.\",\n      \"method\": \"siRNA knockdown of p38 isoforms, overexpression of dominant-negative MKP-1, TonEBP reporter assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — isoform-specific siRNA knockdown and overexpression with reporter assay, single lab\",\n      \"pmids\": [\"18367666\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Phospholipase C-γ1 (PLC-γ1) contributes to TonEBP/OREBP activation by high NaCl. High NaCl induces phosphorylation of TonEBP at Y143; phospho-Y143 creates a binding site for PLC-γ1 (reciprocal co-IP, abolished by Y143A mutation); PLC-γ1 promotes TonEBP transactivating activity and nuclear localization, and is present in the TonEBP-DNA complex.\",\n      \"method\": \"PLC-γ1 null cells, siRNA knockdown, co-immunoprecipitation, Y143A mutagenesis, nuclear localization assay, reporter assay, EMSA\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — null cells, mutagenesis, reciprocal Co-IP, multiple orthogonal functional readouts in one study\",\n      \"pmids\": [\"20080774\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Inducible nucleosome depletion occurs at OREBP/TonEBP binding sites (OREs) in response to hypertonic stress. Initial nucleosome loss is OREBP-independent but is potentiated by OREBP; OREBP-dependent histone hyperacetylation spans the 5' upstream sequences and exons of the aldose reductase gene, but nucleosome loss is not regulated by acetylation status.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP), nucleosome occupancy assays, aldose reductase promoter analysis\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP-based chromatin analysis with OREBP-dependent and -independent conditions, single lab\",\n      \"pmids\": [\"20041176\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"SHP-1 protein tyrosine phosphatase dephosphorylates TonEBP/OREBP at Y143 both in vivo and in vitro, reducing TonEBP nuclear localization and transactivating activity. SHP-1 co-immunoprecipitates with TonEBP. High NaCl inhibits SHP-1 by increasing its phosphorylation at Ser591, which reduces SHP-1 phosphatase activity and nuclear localization, thereby enabling TonEBP activation.\",\n      \"method\": \"Genome-wide phosphatase siRNA screen, siRNA knockdown, overexpression, in vitro phosphatase assay, co-immunoprecipitation, nuclear fractionation\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — genome-wide screen followed by in vitro phosphatase assay, Co-IP, and multiple functional assays; single lab but rigorous multi-method validation\",\n      \"pmids\": [\"20351292\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"c-Abl kinase is responsible for high NaCl-induced phosphorylation of TonEBP/OREBP at Y143 in cell culture and in rat renal inner medulla in vivo. c-Abl associates with TonEBP (co-immunoprecipitation), phosphorylates TonEBP-Y143 in vitro, and its inhibition (imatinib, siRNA, kinase-dead mutant) drastically reduces TonEBP nuclear localization and transactivating activity. High NaCl-induced ATM activation depends on c-Abl activity.\",\n      \"method\": \"Co-immunoprecipitation, in vitro kinase assay, imatinib treatment, siRNA, kinase-dead construct, nuclear fractionation, in vivo renal inner medulla analysis\",\n      \"journal\": \"FASEB journal : official publication of the Federation of American Societies for Experimental Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — in vitro kinase assay plus Co-IP plus multiple genetic and pharmacological approaches plus in vivo validation\",\n      \"pmids\": [\"20585028\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"TonEBP interacts with NF-κB p65 in a tonicity-dependent manner and enhances NF-κB activity at κB elements of NF-κB-responsive genes. This interaction is dependent on Akt signaling. TonEBP affects neither IκBα degradation nor p65 nuclear translocation but acts as a cofactor enhancing NF-κB transcriptional output.\",\n      \"method\": \"Co-immunoprecipitation, reporter assays, kinase inhibition, knockdown in renal epithelial cells and macrophages\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP with functional reporter assays in two cell types, single lab\",\n      \"pmids\": [\"20685965\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"CDK5, activated by high NaCl, directly phosphorylates TonEBP/OREBP at Thr135 (identified by mass spectrometry), contributing to its rapid nuclear localization. Inhibition of CDK5 reduces early (≤4 h) but not late nuclear TonEBP accumulation and transcriptional activity. S155A mutation increases nuclear localization while S134A/T135A mutations decrease it.\",\n      \"method\": \"Mass spectrometry phospho-site mapping, site-directed mutagenesis, CDK5 inhibition, nuclear fractionation, reporter assay, in vivo rat renal medulla phosphorylation analysis\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — mass spectrometry-defined site, mutagenesis, in vitro kinase activity, genetic inhibition, and in vivo verification\",\n      \"pmids\": [\"21209322\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Rac1 and its scaffold OSM (osmosensing scaffold for MEKK3) support TonEBP/OREBP transcriptional/transactivating activity via PLC-γ1, not via p38 MAPK. siRNA knockdown of Rac1 or OSM reduces TonEBP activity; this effect is abolished in PLC-γ1-null cells and restored by PLC-γ1 reconstitution.\",\n      \"method\": \"siRNA knockdown, PLC-γ1 null cells, reconstitution, reporter assay, phosphorylation analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic null cells with reconstitution and epistasis analysis, single lab\",\n      \"pmids\": [\"21712438\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"GSK-3β inhibits TonEBP/NFAT5 by suppressing its transactivating activity (not nuclear localization or protein abundance). High NaCl activates PKA, PI3K, and AKT1 which phosphorylate GSK-3β at Ser9, inhibiting GSK-3β and thereby relieving its suppression of TonEBP.\",\n      \"method\": \"siRNA knockdown, GSK-3β null MEFs, S9A GSK-3β mutant transfection, overexpression of PKA/AKT/p38, reporter assay\",\n      \"journal\": \"American journal of physiology. Renal physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — null MEFs with reconstitution, phosphorylation site mutagenesis, multiple kinase manipulations, single lab\",\n      \"pmids\": [\"23324178\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"IKKβ regulates NFAT5 expression in thymocytes; NFAT5 in turn promotes survival of TCRαβ thymocytes and the β-selection checkpoint transition in an osmostress-independent manner by regulating pro-survival factors A1 and Bcl2 and attenuating the p53/Noxa axis.\",\n      \"method\": \"NFAT5-deficient mice, T cell-specific NFAT5 knockout, IKKβ manipulation, apoptosis assays, gene expression analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO mouse models with defined cellular and molecular phenotypes, single lab\",\n      \"pmids\": [\"24043824\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"PKC-α contributes to high NaCl-dependent NFAT5 activation through ERK1/2 (not through SHP-1-S591). PKC-α knockout reduces NFAT5 protein and target gene expression in the inner medulla, and PKC-α knockdown attenuates NFAT5 transcriptional and transactivating activity; combined knockdown of PKC-α and ERK2 is not additive, indicating a common pathway.\",\n      \"method\": \"PKC-α knockout mice, siRNA knockdown, ERK1/2 phosphorylation analysis, reporter assay, in vivo renal medulla analysis\",\n      \"journal\": \"American journal of physiology. Renal physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo KO plus cell-based siRNA epistasis, single lab\",\n      \"pmids\": [\"25391900\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"TonEBP is required for LPS-induced NF-κB enhanceosome activity in macrophages by recruiting the co-activator p300 to NF-κB; TonEBP molecules incapable of recruiting p300 do not stimulate NF-κB. Myeloid-specific TonEBP deletion reduces inflammation and sepsis severity. The natural compound cerulenin disrupts this TonEBP/NF-κB/p300 enhanceosome without affecting NF-κB activation itself.\",\n      \"method\": \"Myeloid-specific conditional KO mice, p300-recruitment-deficient TonEBP mutants, reporter assays, co-immunoprecipitation, cerulenin treatment, sepsis model\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO in vivo, structure-function mutants for p300 recruitment, mechanistic inhibitor studies; multiple orthogonal methods\",\n      \"pmids\": [\"27118681\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"TonEBP acts as an epigenetic suppressor of white adipose tissue beiging by recruiting DNMT1 DNA methylase to the β3-adrenoreceptor gene promoter, causing promoter methylation and transcriptional silencing. Adipocyte-specific TonEBP deletion or haploinsufficiency prevents high-fat diet-induced obesity and metabolic defects.\",\n      \"method\": \"Adipocyte-specific and haploinsufficient mouse models, ChIP, DNMT1 recruitment assay, promoter methylation analysis, ex vivo and cultured adipocyte reporter assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — conditional KO mouse, ChIP showing DNMT1 recruitment, promoter methylation, in vivo metabolic phenotype with multiple orthogonal methods\",\n      \"pmids\": [\"31387996\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"NFAT5 is selectively required for CD8+ T cell exhaustion in the tumor microenvironment but not during chronic viral infection. NFAT5 transcriptional activity in the tumor context requires hyperosmolarity. NFAT5 overexpression reduces tumor control; deletion reduces TOX and PD-1 expression and increases cytokine production in precursor exhausted PD-1+TCF1+TIM-3- CD8+ T cells.\",\n      \"method\": \"NFAT5 conditional KO mice, NFAT5 overexpression in CD8+ T cells, tumor implantation and LCMV clone 13 infection models, flow cytometry, cytokine assays\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — gain- and loss-of-function in vivo genetic models with defined molecular and cellular phenotypes, comparison of two distinct in vivo contexts\",\n      \"pmids\": [\"37709986\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"TonEBP recognizes R-loops (RNA-DNA hybrids) generated by DNA damaging agents (UV, CPT), binds R-loops via both 3D collision and 1D diffusion along DNA in vitro, and recruits METTL3 to R-loops through its Rel homology domain to promote m6A RNA methylation. TonEBP also recruits RNaseH1 to R-loops through a METTL3 interaction. TonEBP or METTL3 depletion increases R-loop accumulation and reduces cell survival under genotoxic stress.\",\n      \"method\": \"Single-molecule imaging, biochemical R-loop binding assays, co-immunoprecipitation, METTL3 recruitment assay, domain mapping (RHD), RNaseH1 recruitment, siRNA knockdown, cell survival assays\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — single-molecule imaging plus biochemical reconstitution plus Co-IP plus domain mutagenesis plus functional cell viability assays; multiple orthogonal methods\",\n      \"pmids\": [\"33313823\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"PARP1-mediated PARylation of TonEBP is required for its recruitment to sites of R-loop-associated DNA damage induced by camptothecin. TonEBP interacts with PARP1, and loss of TonEBP increases R-loop accumulation and DNA damage and promotes cell death under CPT treatment.\",\n      \"method\": \"Co-immunoprecipitation, PARylation assays, R-loop detection, siRNA knockdown, cell death assays\",\n      \"journal\": \"DNA repair\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus PARP1 inhibition plus functional R-loop and cell death readouts, single lab\",\n      \"pmids\": [\"34049076\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"EGFR activation induces phosphorylated EZH2 (Ser21) binding to NFAT5 and triggers NFAT5 methylation at K668. This methylation prevents NFAT5 interaction with E3 ligase TRAF6 in the cytoplasm, blocking TRAF6-mediated K63-linked ubiquitination and lysosomal degradation, resulting in NFAT5 protein stabilization, nuclear accumulation, and activation. Methylated NFAT5 upregulates MGMT expression, mediating temozolomide resistance in glioblastoma.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assays, site-directed mutagenesis (K668), reporter assays, orthotopic xenograft and PDX models, MGMT expression analysis\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — biochemical characterization of methylation site, ubiquitination mechanism, in vivo xenograft validation, multiple orthogonal methods\",\n      \"pmids\": [\"37429858\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"TonEBP suppresses HO-1 (heme oxygenase-1) expression in M1 macrophages by blocking Nrf2 recruitment to the HO-1 promoter, thereby promoting M1 polarization. TonEBP suppresses IL-10 expression and M2 macrophage phenotype by enhancing chromatin accessibility and Sp1 recruitment to the IL-10 promoter when TonEBP is knocked down.\",\n      \"method\": \"ChIP, siRNA knockdown, reporter assays, neutralizing antibodies, macrophage polarization assays\",\n      \"journal\": \"Frontiers in immunology / Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP assays showing direct promoter binding mechanism plus functional reporter and polarization assays, single lab\",\n      \"pmids\": [\"31057560\", \"27160066\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"In microglia, TonEBP acts as a transcriptional cofactor for both NF-κB and AP-1; LPS induces assembly of a TonEBP/NF-κB/AP-1/p300 complex. Microglial-specific TonEBP deletion blocks LPS-induced pro-inflammatory cytokine expression, microglial activation, and subsequent neuronal cell death and memory loss. Cerulenin disrupts this complex.\",\n      \"method\": \"shRNA knockdown, myeloid-specific conditional KO mice, reporter assays, co-immunoprecipitation, LPS challenge, behavioral memory tests\",\n      \"journal\": \"Journal of neuroinflammation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO in vivo and Co-IP demonstrating complex, single lab\",\n      \"pmids\": [\"33292328\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"NFAT5 controls the expression of CD24 in T cells in response to hypertonicity; NFAT5 binds to the Cd24 promoter in response to hyperosmotic stress, facilitating local chromatin derepression and increased CD24 mRNA and protein expression, which is required to sustain T cell expansion under osmostress.\",\n      \"method\": \"ChIP, chromatin accessibility assay, NFAT5 KO and T cell-specific KO mice, in vitro hypernatremia, flow cytometry\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP with promoter binding plus genetic KO models with in vivo and in vitro functional validation, single lab\",\n      \"pmids\": [\"21037089\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"TonEBP binds the PPARγ2 promoter and blocks the epigenetic transition required for its activation, suppressing adipogenesis and insulin signaling. TonEBP reduction permits PPARγ2 epigenetic remodeling, enhanced adipogenesis, and improved insulin response.\",\n      \"method\": \"ChIP, epigenetic chromatin analysis, reporter assays, knockdown/overexpression, adipogenesis functional assays\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP showing direct promoter occupancy with epigenetic and functional readouts, single lab\",\n      \"pmids\": [\"26042523\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"NFAT5 binds a consensus sequence TGGAAGCGTTC in the promoter of Cacna1c (L-type calcium channel α1C) and activates its transcription. siRNA knockdown of Nfat5 suppresses Cacna1c expression and decreases L-type calcium current in neonatal cardiomyocytes; morpholino-mediated knockdown in zebrafish abolishes cacna1c expression and results in non-contractile ventricle, rescued by overexpression of either cacna1c or nfat5.\",\n      \"method\": \"Promoter binding/reporter assay, siRNA knockdown, electrophysiology (L-type Ca2+ current), zebrafish morpholino knockdown, rescue experiments\",\n      \"journal\": \"Journal of molecular medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — promoter binding confirmed, electrophysiology, and in vivo zebrafish genetic model with rescue; multiple orthogonal methods\",\n      \"pmids\": [\"27368804\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Aurora kinase B (AURKB) phosphorylates NFAT5, enhancing its protein stability and nuclear translocation, which directly controls AQP4 (aquaporin-4) expression in astrocytes. The AURKB-NFAT5-AQP4 pathway regulates astrocyte swelling and contributes to neuropathic pain in the spinal dorsal horn.\",\n      \"method\": \"Phosphorylation assays, protein stability assays, nuclear translocation assays, AQP4 promoter reporter, spinal cord neuropathic pain model, selective astrocyte vs. microglia analysis\",\n      \"journal\": \"Advanced science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mechanistic pathway (AURKB→NFAT5 phosphorylation→AQP4) defined with functional in vivo pain model, single lab\",\n      \"pmids\": [\"38195869\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"NLRC3 inhibits NF-κB p65 binding to the NFAT5 promoter by decreasing NF-κB activation and p300 co-activator activity through sequestration of mTOR and p300 in the NLRC3-mTOR-p300 complex, reducing NFAT5-dependent glycolytic gene expression in immunosuppressed macrophages.\",\n      \"method\": \"Myeloid-specific NLRC3 deletion, co-immunoprecipitation of NLRC3-mTOR-p300 complex, ChIP for p65 at NFAT5 promoter, glycolysis assays\",\n      \"journal\": \"Molecular therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP demonstrating protein complex, ChIP showing p65 binding, conditional KO, single lab\",\n      \"pmids\": [\"36068919\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Serum amyloid A (SAA) activates NFAT5 expression and activity in macrophages via the TLR2/4-JNK signaling pathway. The SAA-TLR2/4-NFAT5 axis promotes macrophage migration and chemotaxis in an IL-6- and CCL2-dependent manner. Genetic ablation of NFAT5 or TLR2/4 rescues SAA-induced arthritis pathology in mice.\",\n      \"method\": \"In vitro macrophage stimulation with SAA, TLR2/4 and NFAT5 genetic KO mice, JNK pathway inhibition, migration/chemotaxis assays, intraarticular SAA injection model\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO in vivo with signaling pathway analysis, single lab\",\n      \"pmids\": [\"38426494\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"NFAT5 (TonEBP/OREBP) is a constitutively nuclear, homodimeric Rel-family transcription factor that completely encircles its TonE/ORE DNA target; it is activated by hypertonic stress through a multi-kinase cascade involving c-Abl-mediated phosphorylation at Y143 (enabling PLC-γ1 binding), CDK5-mediated phosphorylation at T135 (driving rapid nuclear import), ATM-mediated phosphorylation at multiple Ser sites, and p38α/ERK/PKC-α signaling acting on its C-terminal transactivation domain, while GSK-3β and SHP-1 phosphatase restrain its activity and RHA inhibits it via the E'F loop; beyond osmostress, NFAT5 serves as a transcriptional cofactor for NF-κB and AP-1 (recruiting p300 to form an enhanceosome), suppresses competing transcription factors (blocking Nrf2 at the HO-1 promoter, blocking epigenetic activation of PPARγ2), recruits DNMT1 to methylate target gene promoters, and in the DNA damage response recognizes R-loops via its Rel homology domain to recruit METTL3 for m6A methylation-dependent R-loop resolution; additionally, EZH2-mediated K668 methylation stabilizes NFAT5 by blocking TRAF6-dependent ubiquitination and lysosomal degradation, and AURKB phosphorylation enhances its stability and nuclear translocation.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"NFAT5 (TonEBP/OREBP) is a constitutively nuclear, Rel-family transcription factor that translates osmotic and inflammatory stress into transcriptional programs governing cellular survival and adaptation [#0, #3]. Unlike calcineurin-regulated NFAT1-4, it carries an NFAT-like Rel homology domain that binds TonE/ORE elements but lacks Fos/Jun cooperativity, and its nuclear localization is calcineurin-independent [#0]; structurally it acts as a homodimer that completely encircles its DNA target, conferring kinetic stability to the complex, with C-terminal Rel-homology dimerization required for both DNA binding and proper phosphorylation [#1, #2]. Hypertonic stress is relayed to NFAT5 through a multi-kinase network acting on distinct steps: c-Abl phosphorylates Y143 to create a PLC-\\u03b31 docking site driving nuclear localization and transactivation [#13, #16], CDK5 phosphorylates T135 to promote rapid early nuclear import [#18], ATM (downstream of c-Abl) phosphorylates C-terminal Ser sites and supports nuclear translocation [#5, #7, #16], and a p38\\u03b1/ERK/PKC-\\u03b1 axis acts on the osmotically regulated C-terminal transactivation domain [#3, #4, #22], while SHP-1 (dephosphorylating Y143) and GSK-3\\u03b2 restrain activity and RNA helicase A inhibits it via the E'F loop [#9, #15, #20]. Beyond osmoadaptation, NFAT5 is a transcriptional cofactor that recruits p300 to NF-\\u03baB and AP-1 to form pro-inflammatory enhanceosomes in macrophages and microglia [#23, #30], and it operates as an epigenetic repressor by recruiting DNMT1 to methylate target promoters and by blocking the epigenetic activation of PPAR\\u03b32 and Nrf2-driven HO-1 [#24, #29, #32]. NFAT5 directly activates lineage- and tissue-specific targets including Cacna1c in cardiomyocytes, CD24 in T cells, and AQP4 in astrocytes [#31, #33, #34], and in the DNA damage response it recognizes R-loops through its Rel homology domain to recruit METTL3 and RNaseH1 for m6A-dependent R-loop resolution, an event requiring PARP1-mediated PARylation [#26, #27]. NFAT5 protein stability is controlled by EZH2-mediated K668 methylation, which blocks TRAF6-dependent K63 ubiquitination and lysosomal degradation, and by AURKB phosphorylation [#28, #34].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Established that NFAT5 is a distinct Rel-family transcription factor with NFAT-like DNA-binding but constitutive, calcineurin-independent nuclear residence, defining it as mechanistically separate from NFAT1-4.\",\n      \"evidence\": \"DNA-binding and reporter assays, immunofluorescence localization, contact-residue sequence analysis\",\n      \"pmids\": [\"10377394\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the activating signal or post-translational regulation\", \"Did not establish target gene repertoire\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Resolved the structural basis of DNA recognition, showing NFAT5 forms an NF-\\u03baB-like homodimer that encircles its TonE target for kinetic stability, and that CRHD-mediated dimerization is required for DNA binding and phosphorylation.\",\n      \"evidence\": \"X-ray crystallography, EMSA, DNA-binding kinetics, deletion mutagenesis\",\n      \"pmids\": [\"11780147\", \"12074571\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not connect dimerization to upstream signaling\", \"Structure of the transactivation domain not resolved\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Localized osmotic regulation to the C-terminal transactivation domain controlled by tonicity-driven phosphorylation, implicating p38 MAPK, Fyn, and tyrosine/CK2 kinases as the activating effectors.\",\n      \"evidence\": \"GAL4-TAD reporter assays, dominant-negative mutants, pharmacological inhibition, Fyn-deficient cells\",\n      \"pmids\": [\"11792870\", \"12359721\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not map specific phosphosites\", \"Did not order kinases into a cascade\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Connected high-NaCl-induced DNA damage signaling to NFAT5 by showing ATM physically associates with and phosphorylates it at defined Ser sites and supports nuclear translocation, linking genotoxic and osmotic stress responses.\",\n      \"evidence\": \"Reciprocal Co-IP, S1197A/S1247A/S1367A mutagenesis, ATM-deficient cell reconstitution, fractionation\",\n      \"pmids\": [\"15173573\", \"15840767\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not place ATM relative to other upstream kinases\", \"Mechanism of ATM activation by NaCl not fully defined here\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Identified parallel non-transcriptional inputs raising NFAT5 abundance and activity, namely 5'-UTR-dependent mRNA stabilization and mitochondrial superoxide enhancing transactivation without affecting nuclear import.\",\n      \"evidence\": \"Actinomycin D chase, UTR luciferase reporters, ROS-source inhibitors, ORE reporter and target mRNA assays\",\n      \"pmids\": [\"15900024\", \"15769933\", \"16303854\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"ROS sensor on NFAT5 not identified\", \"mRNA-stabilizing trans-factors unknown\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Defined the nucleocytoplasmic shuttling machinery and an inhibitory interactome, showing CRM1-dependent NES-mediated export and identifying RHA (E'F loop) and proteomically a DNA-PK/PARP-1/Hsp90 network as activity modulators.\",\n      \"evidence\": \"NES mutagenesis, BiFC with CRM1, leptomycin B, domain-mapped Co-IP, MS-based proteomics with EMSA/reporter validation\",\n      \"pmids\": [\"16782704\", \"16173919\", \"17148781\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional roles of many co-purifying proteins not dissected\", \"Mechanism of tonicity-induced RHA dissociation unresolved\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Established the proximal tyrosine-phosphorylation switch: c-Abl phosphorylates Y143 to recruit PLC-\\u03b31, driving nuclear localization and transactivation, with c-Abl also required for ATM activation.\",\n      \"evidence\": \"PLC-\\u03b31 null cells, Y143A mutagenesis, reciprocal Co-IP, in vitro kinase assays, imatinib/siRNA, in vivo renal medulla\",\n      \"pmids\": [\"20080774\", \"20585028\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How PLC-\\u03b31 enhances transactivation mechanistically unclear\", \"Upstream osmosensor for c-Abl not defined\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Defined opposing positive and negative regulators that fine-tune NFAT5: SHP-1 dephosphorylates Y143 to restrain activity (relieved by NaCl-induced SHP-1 Ser591 inhibition), while p38 isoforms exert opposing (p38\\u03b1 activating, p38\\u03b4 inhibiting) effects.\",\n      \"evidence\": \"Genome-wide phosphatase siRNA screen, in vitro phosphatase assay, Co-IP, isoform-specific siRNA, reporter assays\",\n      \"pmids\": [\"20351292\", \"18367666\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Integration of opposing p38 isoform signals in vivo unclear\", \"How NaCl phosphorylates SHP-1 Ser591 not defined\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Resolved temporal control and an additional upstream branch: CDK5 phosphorylates T135 for rapid early nuclear import, and a Rac1/OSM scaffold feeds into NFAT5 via PLC-\\u03b31 rather than p38.\",\n      \"evidence\": \"MS phosphosite mapping, S134A/T135A mutagenesis, CDK5 inhibition, PLC-\\u03b31 null reconstitution, in vivo renal medulla\",\n      \"pmids\": [\"21209322\", \"21712438\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Coordination of early CDK5 versus late ATM/c-Abl inputs incomplete\", \"Osmosensing event upstream of Rac1/OSM unknown\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Extended NFAT5 biology beyond osmostress, showing IKK\\u03b2-driven NFAT5 promotes thymocyte survival and \\u03b2-selection osmostress-independently, while GSK-3\\u03b2 suppresses transactivation and is relieved by PKA/PI3K/AKT1.\",\n      \"evidence\": \"NFAT5-deficient and T cell-specific KO mice, GSK-3\\u03b2 null MEFs, S9A mutant, kinase overexpression, reporter assays\",\n      \"pmids\": [\"24043824\", \"23324178\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Osmostress-independent activation mechanism in thymocytes not fully defined\", \"How GSK-3\\u03b2 suppresses TAD mechanistically unknown\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Completed the serine/threonine activation branch by placing PKC-\\u03b1 upstream of ERK1/2 (independent of SHP-1) to drive NFAT5 protein and target gene expression in the renal medulla.\",\n      \"evidence\": \"PKC-\\u03b1 KO mice, siRNA epistasis with ERK2, reporter assays, in vivo renal medulla analysis\",\n      \"pmids\": [\"25391900\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"ERK target residues on NFAT5 not mapped\", \"Crosstalk with the c-Abl/PLC-\\u03b31 branch unresolved\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Defined NFAT5 as a transcriptional cofactor building inflammatory enhanceosomes by recruiting p300 to NF-\\u03baB and as an epigenetic repressor blocking Nrf2 at the HO-1 promoter, linking it to macrophage polarization and sepsis.\",\n      \"evidence\": \"Myeloid-specific KO mice, p300-recruitment-deficient mutants, Co-IP, ChIP, cerulenin disruption, sepsis model\",\n      \"pmids\": [\"27118681\", \"31057560\", \"27160066\", \"20685965\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of p300 recruitment not defined\", \"Generality of enhanceosome across inflammatory genes unclear\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Demonstrated direct, tissue-specific gene activation by NFAT5 at a defined consensus, establishing it as a transcriptional driver of Cacna1c and L-type calcium current essential for cardiac contractility.\",\n      \"evidence\": \"Promoter binding/reporter assays, siRNA, electrophysiology, zebrafish morpholino knockdown with cacna1c/nfat5 rescue\",\n      \"pmids\": [\"27368804\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cofactor requirements at the Cacna1c promoter not defined\", \"Osmotic dependence of cardiac NFAT5 activity not addressed\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Established NFAT5 as a recruiter of DNMT1 to methylate and silence target promoters, defining a DNA-methylation-based repressive mechanism controlling adipose beiging and metabolic phenotype.\",\n      \"evidence\": \"Adipocyte-specific and haploinsufficient mice, ChIP, DNMT1 recruitment, promoter methylation, metabolic phenotyping\",\n      \"pmids\": [\"31387996\", \"26042523\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How NFAT5 selects DNMT1 target promoters unknown\", \"Reversibility of established methylation marks not addressed\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Uncovered a non-transcriptional genome-maintenance function in which NFAT5 recognizes R-loops via its Rel homology domain and recruits METTL3 (m6A) and RNaseH1 for R-loop resolution, with PARP1-dependent PARylation enabling recruitment to damage sites.\",\n      \"evidence\": \"Single-molecule imaging, biochemical R-loop binding, domain-mapped Co-IP, METTL3/RNaseH1 recruitment, PARylation assays, survival assays\",\n      \"pmids\": [\"33313823\", \"34049076\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relationship between DNA-binding and R-loop-binding modes unclear\", \"Whether transcriptional and R-loop functions are coupled unknown\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Defined methylation-controlled protein stability: EGFR-driven phospho-EZH2 methylates NFAT5 at K668, blocking TRAF6-mediated K63 ubiquitination and lysosomal degradation, stabilizing NFAT5 to drive MGMT-dependent temozolomide resistance.\",\n      \"evidence\": \"Co-IP, ubiquitination assays, K668 mutagenesis, reporter assays, orthotopic xenograft and PDX models\",\n      \"pmids\": [\"37429858\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether K668 methylation interfaces with osmotic activation unknown\", \"Demethylase reversing the mark not identified\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Extended NFAT5's pathological roles, showing AURKB phosphorylation stabilizes NFAT5 to drive AQP4 and astrocyte swelling in neuropathic pain, and SAA-TLR2/4-JNK signaling activates NFAT5 to promote macrophage chemotaxis in arthritis.\",\n      \"evidence\": \"Phosphorylation and stability assays, AQP4 reporter, neuropathic pain and SAA-arthritis models, TLR2/4 and NFAT5 KO mice, JNK inhibition\",\n      \"pmids\": [\"38195869\", \"38426494\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"AURKB phosphosites on NFAT5 not mapped\", \"Whether JNK acts on NFAT5 protein directly unclear\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the multiple parallel kinase, phosphatase, methylation, and PARylation inputs are integrated to produce context-specific NFAT5 transcriptional versus genome-maintenance outputs remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model coordinating osmotic, inflammatory, and DNA-damage activation modes\", \"Structural basis distinguishing TonE-DNA binding from R-loop recognition unknown\", \"Selectivity determinants for activating versus repressive (DNMT1-recruiting) target promoters undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 3, 23, 24, 31, 33]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 1, 2, 33]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [23, 24, 26, 30]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 7, 10, 18]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [10, 28]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [0, 3, 4, 13, 18]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [23, 24, 31, 33]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [21, 23, 25, 29, 30, 36]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [5, 26, 27]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [14, 24, 29, 31, 32]}\n    ],\n    \"complexes\": [\n      \"TonEBP/NF-\\u03baB/p300 enhanceosome\",\n      \"TonEBP/NF-\\u03baB/AP-1/p300 complex\"\n    ],\n    \"partners\": [\n      \"PLCG1\",\n      \"ABL1\",\n      \"ATM\",\n      \"CDK5\",\n      \"PTPN6\",\n      \"METTL3\",\n      \"PARP1\",\n      \"EZH2\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"tie","faith_supported":6,"faith_total":6,"faith_pct":100.0}}